Form 8-K

8-K — NeoVolta Inc.

Accession: 0001683168-26-002339

Filed: 2026-03-27

Period: 2026-03-26

CIK: 0001748137

SIC: 3690 (MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES)

Item: Entry into a Material Definitive Agreement

Item: Financial Statements and Exhibits

Documents

8-K — neovolta_8k.htm (Primary)

EX-1.1 — SALES AGREEMENT, DATED MARCH 27, 2026 (neovolta_ex0101.htm)

EX-5.1 — OPINION OF ARENTFOX SCHIFF LLP (neovolta_ex0501.htm)

EX-10.1 — FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (neovolta_ex1001.htm)

GRAPHIC (image_001.jpg)

GRAPHIC (image_002.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: neovolta_8k.htm · Sequence: 1

NeoVolta, Inc 8-K

false

0001748137

2026-03-26

0001748137

us-gaap:CommonStockMember

2026-03-26

0001748137

us-gaap:WarrantMember

2026-03-26

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND

EXCHANGE COMMISSION

Washington, D.C.

20549

FORM

8-K

CURRENT REPORT

Pursuant to Section

13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date

of earliest event reported): March 26,

2026

NeoVolta,

Inc.

(Exact name of registrant

as specified in its charter)

Nevada

001-41447

82-5299263

(State or Other Jurisdiction

(Commission

(I.R.S. Employer

of Incorporation)

File Number)

Identification No.)

12195

Dearborn Place

Poway, CA 92064

(Address of Principal

Executive Offices) (Zip Code)

(800) 364-5464

(Registrant’s

telephone number, including area code)

(Former name or former address,

if changed since last report)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy

the filing obligation of the registrant under any of the following provisions:

☐

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol (s)

Name

of each exchange on which registered

Common Stock, par value $0.001 per share

NEOV

The NASDAQ Stock Market LLC

Warrants, each warrant exercisable for one share of common stock

NEOVW

The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry

into a Material Definitive Agreement.

On March 27, 2026, NeoVolta,

Inc. (the “Company”), entered into a Sales Agreement (the "Sales Agreement") with Needham & Company, LLC ("Needham").

Pursuant to the terms of the Sales Agreement, the Company may sell from time to time through Needham, as sales agent, shares of the Company's

common stock, par value $0.001 per share ("Shares") having an aggregate offering price of up to $30,000,000. The Company intends

to use the net proceeds from the sale of the Shares for working capital and for general corporate purposes.

Any sale of Shares pursuant

to the Sales Agreement will be made under the Company's effective "shelf" registration statement on Form S-3 (File No. 333-280400),

which was declared effective by the Securities and Exchange Commission (the "SEC") on June 28, 2024, which includes the base

prospectus, and under the related prospectus supplement (the "Prospectus Supplement") dated March 27, 2026, filed with the SEC.

The Shares that may be offered, issued, and sold under the Prospectus Supplement are included in the $75,000,000 of securities that may

be offered, issued, and sold by the Company under the base prospectus.

Under the Sales Agreement,

the Company may offer and sell Shares through Needham acting as sales agent. Sales can be made by any method permitted by law and deemed

to be an "at the market offering" as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended (the "Securities

Act"), including sales made directly on or through the Nasdaq Capital Market, on any other existing trading market for the Company's

common stock, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market

prices, and/or any other method permitted by law.

Upon delivery of a placement

notice and subject to the terms and conditions of the Sales Agreement, Needham is required to use its commercially reasonable efforts

consistent with its normal trading and sales practices to sell such Shares from time to time based upon the Company's instructions, including

with regard to the number of shares to be issued, the dates on which such sales may be made, any limitation on the number of shares to

be sold in any one day and any minimum price below which sales may not be made. Any sales by Needham on a principal basis will be pursuant

to a separate written agreement setting forth the terms of such sale.

The Company or Needham may,

upon notice to the other party in writing or by telephone, suspend any sale of Shares under the Sales Agreement. The Company will ensure

that no sale of Shares will take place during any period in which the Company is in possession of material non-public information. The

Company is not obligated to make any sales under the Sales Agreement, and any sales will depend on market conditions and the Company's

capital needs.

Needham will be paid a commission

equal to 3.0% of the aggregate gross proceeds from each sale of Shares sold pursuant to the Sales Agreement. In addition, the Company

has agreed to reimburse Needham for certain expenses in an amount not to exceed $100,000 in connection with the establishment of the ATM

offering and $10,000 for each periodic update. The Company has also agreed to indemnify Needham against certain liabilities, including

liabilities under the Securities Act.

The offering will terminate

upon the sale of Shares in an aggregate amount specified in the Sales Agreement or sooner if terminated by either party. Either party

may terminate the Sales Agreement by giving five days' prior written notice to the other party, and Needham may also terminate the Sales

Agreement immediately upon the occurrence of certain adverse events.

The representations, warranties

and covenants contained in the Sales Agreement were made solely for the benefit of the parties to the Sales Agreement, and may be subject

to limitations agreed upon by the contracting parties. Accordingly, the Sales Agreement is incorporated herein by reference only to provide

investors with information regarding the terms of the Sales Agreement and not to provide investors with any other factual information

regarding the Company or its business, and should be read in conjunction with the disclosures in the Company’s periodic report and

other filings with the SEC.

The foregoing description

of the Sales Agreement is not complete and is qualified in its entirety by reference to the full text of the Sales Agreement, a copy of

which is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.

A copy of the opinion of ArentFox

Schiff LLP relating to the legality of the Shares issuable under the Sales Agreement and Prospectus Supplement is filed as Exhibit 5.1

to this Current Report on Form 8-K and is also incorporated by reference into the Registration Statement.

The above disclosure shall

not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer,

solicitation, or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration

or qualification under the securities laws of any such state.

Item 5.02 Departure of

Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain

Officers.

On March 26, 2026, the Board

of Directors (the “Board”) of the Company appointed Steve Bond, age 52, as Executive Vice President of the Company, effective

immediately. Mr. Bond has served as the Company’s Chief Financial Officer since February 4, 2025, pursuant to that certain Employment

Agreement, dated as of February 4, 2025, by and between the Company and Mr. Bond (the “Bond Employment Agreement”). In connection

with Mr. Bond’s appointment as Executive Vice President, the Board determined that Mr. Bond’s service as Chief Financial Officer

of the Company will terminate effective as of May 18, 2026.

There are no arrangements

or understandings between Mr. Bond and any other persons pursuant to which he was appointed as Executive Vice President. There are no

family relationships between Mr. Bond and any director or executive officer of the Company, and Mr. Bond has no direct or indirect material

interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

In connection with the foregoing

changes to Mr. Bond’s title and role, on March 26, 2026, the Board approved a First Amendment to the Bond Employment Agreement (the

“Amendment”). The Amendment reflects the transition of Mr. Bond’s role from Chief Financial Officer to Executive Vice

President. A copy of the Amendment is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text

of the Amendment.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Exhibit Description

1.1†

Sales Agreement, dated March 27, 2026, by and between NeoVolta, Inc. and Needham & Company, LLC.

5.1

Opinion of ArentFox Schiff LLP.

10.1

First Amendment to Employment Agreement dated March 26, 2026 between NeoVolta, Inc. and Steve Bond

23.1

Consent of ArentFox Schiff LLP (included in Exhibit 5.1).

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

† Certain of the schedules to this Exhibit have been omitted

in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted schedules to the SEC upon its

request.

SIGNATURE

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

NeoVolta, Inc.

By:

/s/ Steve Bond

Steve Bond

Chief Financial Officer

Dated: March 27, 2026

EX-1.1 — SALES AGREEMENT, DATED MARCH 27, 2026

EX-1.1

Filename: neovolta_ex0101.htm · Sequence: 2

Exhibit 1.1

NeoVolta, Inc.

Shares of Common Stock

SALES AGREEMENT

March 27, 2026

Needham

& Company, LLC

250 Park Avenue

New York, New York 10177

Ladies and Gentlemen:

NeoVolta, Inc., a Nevada corporation

(the “Company”), confirms as follows its agreements with Needham & Company, LLC (the “Sales Agent”).

1.Issuance

and Sale of Shares.

(a)On

the basis of the representations, warranties and agreements of the Company herein contained and subject to all the terms and conditions

of this Sales Agreement (the “Agreement”), the Company agrees that, from time to time during the term of this Agreement,

it may issue and sell through the Sales Agent shares of common stock (the “Placement Shares”) of the Company, par value $0.001

per share (the “Common Stock”); provided, however, that in no event shall the Company issue or sell through

the Sales Agent such number or dollar amount of Placement Shares that would (i) exceed the number or dollar amount of shares of Common

Stock registered on the effective Registration Statement (as defined below) pursuant to which the offering is being made, (ii) exceed

the number of authorized but unissued shares of Common Stock (less shares of Common Stock issuable upon exercise, conversion or exchange

of any outstanding securities of the Company or otherwise reserved from the Company’s authorized capital stock), (iii) exceed the

number or dollar amount of shares of Common Stock permitted to be sold by the Company under Form S-3 (including General Instruction I.B.6.

thereof, if applicable) or (iv) exceed the number or dollar amount of shares of Common Stock for which the Company has filed a Prospectus

Supplement (as defined below) (the lesser of clauses (i), (ii), (iii) and (iv), the “Maximum Amount”). Notwithstanding anything

to the contrary contained herein, the parties hereto agree that compliance with the limitations set forth in this Section 1 on the number

or dollar amount of Placement Shares that may be issued and sold under this Agreement shall be the sole responsibility of the Company

and the Sales Agent shall have no obligation in connection with such compliance. The issuance and sale of Placement Shares through the

Sales Agent will be effected pursuant to the Registration Statement filed by the Company with the Securities and Exchange Commission (the

“Commission”) on June 21, 2024 and declared effective by the Commission on June 28, 2024, although nothing in this Agreement

shall be construed as requiring the Company to issue shares of Common Stock.

(b)The

Company has filed, in accordance with the provisions of the Securities Act of 1933 (the “Act”), and the rules and regulations

of the Commission thereunder (collectively referred to as the “Rules and Regulations”), with the Commission a registration

statement on Form S-3 (File No. 333-280400), including a base prospectus and together with such amendments thereto as may have been required

to the date of this Agreement, relating to the Common Stock to be issued from time to time by the Company, and which incorporates by reference

documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended

(the “Exchange Act”), and the rules and regulations of the Commission thereunder (collectively, the “Exchange Act Rules

and Regulations”). The Company has prepared a prospectus supplement to the base prospectus included as part of the registration

statement, which prospectus supplement relates to the Placement Shares to be issued from time to time by the Company pursuant to this

Agreement (the “Prospectus Supplement”). The Company will furnish to the Sales Agent, for use by the Sales Agent, copies of

the base prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement. The Company may file

one or more additional registration statements from time to time that will contain a base prospectus and a related prospectus supplement,

if applicable (which shall be a Prospectus Supplement), with respect to the Placement Shares. Except where the context otherwise requires,

any such registration statement, including the amendments thereto, the exhibits and any schedules thereto, the documents otherwise deemed

to be part thereof, included or incorporated by reference therein, and including any information contained in a Prospectus (as defined

below) subsequently filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations (“Rule 424(b)”) or deemed

to be a part of such registration statement pursuant to the Rules and Regulations (including Rule 430B thereof), and any registration

statement relating to the offering contemplated by this Agreement and filed pursuant to Rule 462(b) of the Rules and Regulations (“Rule

462(b)”) is herein called the “Registration Statement.” The base prospectus or base prospectuses, including all documents

incorporated by reference therein, included in the Registration Statement, as it may be supplemented, if applicable, by the Prospectus

Supplement, in the form in which such prospectus or prospectuses and/or Prospectus Supplement have most recently been filed by the Company

with the Commission pursuant to Rule 424(b), together with any then-issued Issuer Free Writing Prospectuses (as defined below), is herein

called the “Prospectus.”

(c)Any

reference herein to the Registration Statement, any base prospectus, any Prospectus Supplement, the Prospectus or any Issuer Free Writing

Prospectus shall be deemed to refer to and include the documents, if any, that are or are deemed to be incorporated by reference therein

or from which information is so incorporated by reference (the “Incorporated Documents”), including, unless the context otherwise

requires, the documents, if any, filed as exhibits to such Incorporated Documents. Any reference herein to the terms “amend,”

“amendment” or “supplement” with respect to the Registration Statement, any base prospectus, any Prospectus Supplement,

the Prospectus or any Issuer Free Writing Prospectus shall be deemed to refer to and include the filing of any document under the Exchange

Act on or after the most recent effective date of the Registration Statement, or the respective dates of the base prospectus, such Prospectus

Supplement, the Prospectus or such Issuer Free Writing Prospectus, as the case may be, and deemed to incorporated by reference therein.

For purposes of this Agreement, all references to the Registration Statement, the Prospectus or any amendment or supplement thereto shall

be deemed to include the most recent copy filed with the Commission pursuant to its Electronic Data Gathering Analysis and Retrieval system

or, if applicable, the Interactive Data Electronic Application system when used by the Commission (collectively, “EDGAR”).

2.Placements.

Each time that the Company wishes to issue and sell Placement Shares hereunder (each, a “Placement”), it will notify the Sales

Agent by email notice (or other method mutually agreed to by the parties) (each such notice, a “Placement Notice”) containing

the parameters in accordance with which the Company desires such Placement Shares to be sold, which at a minimum shall include the maximum

number or amount of Placement Shares to be sold, the time period during which sales are requested to be made, any limitation on the number

or amount of Placement Shares that may be sold in any day on which the Common Stock is traded on the Exchange (any such day, a “Trading

Day”) and any minimum price below which sales may not be made, the form of which is attached hereto as Schedule 1. The Placement

Notice shall originate from any of the individuals from the Company set forth on Schedule 3 (with a copy to each of the other individuals

from the Company listed on such Schedule 3), and shall be addressed to each of the individuals from the Sales Agent set forth on Schedule

3, as such Schedule 3 may be amended from time to time. The Placement Notice shall be effective upon receipt by the Sales Agent unless

and until (a) the Sales Agent declines to accept the terms contained therein for any reason, in its sole discretion, (b) the

Sales Agent suspends sales under the Placement Notice for any reason in its sole discretion in accordance with this Agreement, (c) the

entire number or amount of the Placement Shares thereunder or under this Agreement have been sold, (d) the Company suspends or terminates

the Placement Notice or (e) this Agreement has been terminated under the provisions of Section 11. The amount of any discount, commission

or other compensation to be paid by the Company to the Sales Agent in connection with the sale of the Placement Shares shall be calculated

in accordance with the terms set forth in Schedule 2. Notwithstanding the foregoing, in the event the Company engages a Sales Agent for

a sale of Placement Shares in a Placement that would constitute a “distribution” within the meaning of Rule 100 of Regulation

M under the Exchange Act (“Regulation M”) or a “block” within the meaning of Rule 10b-18(a)(5) under the Exchange

Act, the Company will provide the Sales Agent, at such Sales Agent’s request and upon reasonable advance notice to the Company,

on or prior to the Settlement Date, the opinions of counsel, accountants’ letters and officers’ certificates pursuant to Section

8 hereof, each dated the Settlement Date, and such other documents and information as the Sales Agent shall reasonably request, and the

Company and the Sales Agent will agree to compensation that is customary for the Sales Agent with respect to such transaction. It is expressly

acknowledged and agreed that neither the Company nor the Sales Agent will have any obligation whatsoever with respect to a Placement or

any Placement Shares unless and until the Company delivers a Placement Notice to the Sales Agent and the Sales Agent does not decline

such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event of

a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control with

respect to the matters covered thereby.

3.Sale

of Placement Shares by the Sales Agent. On the basis of the representations, warranties and agreements of the Company herein contained

and subject to all the terms and conditions of this Agreement, upon the Sales Agent’s acceptance of the terms of a Placement Notice,

and unless the sale of the Placement Shares described therein has been declined, suspended or otherwise terminated in accordance with

the terms of this Agreement, the Sales Agent, for the period specified in the Placement Notice, will use its commercially reasonable efforts

consistent with its normal trading and sales practices and applicable laws and regulations and the rules of the Nasdaq Stock Market LLC

(the “Exchange”) to sell such Placement Shares up to the number or amount specified in, and otherwise in accordance with the

terms of, such Placement Notice. The Sales Agent will provide written confirmation to the Company no later than the opening of the Trading

Day immediately following the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number or amount

of Placement Shares sold on such Trading Day, the average price at which Placement Shares were sold and the gross proceeds generated from

such sales. Subject to the terms of the Placement Notice, the Sales Agent may sell Placement Shares by any method permitted by law deemed

to be an “at the market offering” as defined in Rule 415(a)(4) of the Rules and Regulations, including sales made directly

on or through the Exchange or any other existing trading market for the Common Stock, in negotiated transactions at market prices prevailing

at the time of sale or at prices related to such prevailing market prices and/or any other method permitted by law. The Company acknowledges

and agrees that (a) there can be no assurance that the Sales Agent will be successful in selling Placement Shares, (b) the Sales Agent

will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason

other than a failure by the Sales Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices

and applicable laws and regulations to sell such Placement Shares as required under this Agreement and (c) the Sales Agent shall be under

no obligation to purchase Placement Shares on a principal basis pursuant to this Agreement, except as otherwise agreed by the Sales Agent

and the Company in a separate written agreement setting forth the terms of such sale.

4.Suspension

of Sales.

(a)The

Company or the Sales Agent may, upon notice to the other party in writing (including by email correspondence to each of the individuals

of the other party set forth on Schedule 3, if receipt of such correspondence is actually acknowledged by any of the individuals to whom

the notice is sent, other than automatic reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence

to each of the individuals of the other party set forth on Schedule 3), suspend any sale of Placement Shares (each, a “Suspension”);

provided, however, that such Suspension shall not affect or impair any party’s obligations with respect to any Placement

Shares sold hereunder prior to the receipt of such notice. While a Suspension is in effect, any obligation under Sections 7(s), 7(t),

and 7(u) with respect to the delivery of certificates, opinions and comfort letters to the Sales Agent, shall be waived. Each of the parties

agrees that no notice under this Section 4 shall be effective against the other party unless notice is sent by one of the individuals

named on Schedule 3 hereto to one of the individuals named on Schedule 3 hereto, as such Schedule may be amended from time to time.

(b)Notwithstanding

any other provision of this Agreement, during any period in which the Company is, or would reasonably be deemed to be, in possession of

material non-public information, the Company and the Sales Agent agree that (i) no sale of Placement Shares will take place, (ii) the

Company shall not request the sale of any Placement Shares and shall cancel any effective Placement Notices instructing the Sales Agent

to make any sales and (iii) the Sales Agent shall not be obligated to sell or offer to sell any Placement Shares.

5.Settlement

and Delivery.

(a)Unless

otherwise specified in the applicable Placement Notice, settlement for sales of Placement Shares will occur on the first Trading Day (or

such other day as is industry practice for regular-way trading) following the date on which such sales are made (each, a “Settlement

Date”). The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold

(the “Net Proceeds”) will be equal to the aggregate gross sales price received by the Sales Agent, after deduction of (i)

the Sales Agent’s commission, discount or other compensation for such sales payable by the Company pursuant to Section 2 hereof,

(ii) any other amounts due and payable by the Company to the Sales Agent pursuant to Section 7(i) of this Agreement and (iii) any transaction

fees imposed by any governmental or self-regulatory organization in respect of such sales.

(b)On

or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement Shares being

sold by crediting the Sales Agent’s or its designee’s account (provided the Sales Agent shall have given the Company written

notice of such designee at least one Trading Day prior to the Settlement Date) at The Depository Trust Company through its Deposit and

Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto, which in all cases

shall be duly authorized, freely tradeable, transferable, registered shares of Common Stock in good deliverable form. On each Settlement

Date, the Sales Agent will deliver the related Net Proceeds in same day funds to an account designated by the Company on or prior to the

Settlement Date. In addition to and in no way limiting the rights and obligations set forth in Section 9 hereto, the Company agrees that

if the Company or its transfer agent (if applicable), defaults in its obligation to deliver duly authorized, freely tradeable, transferable,

registered Placement Shares on a Settlement Date, the Company will (i) hold the Sales Agent harmless against any loss, claim, damage,

or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company

or its transfer agent (if applicable), (ii) pay to the Sales Agent any commission, discount or other compensation to which it would otherwise

have been entitled absent such default and (iii) take all necessary action to cause the full amount of any Net Proceeds that were delivered

to the Company’s account with respect to such settlement, together with any costs incurred by the Sales Agent in connection with

recovering such Net Proceeds, to be immediately returned to the Sales Agent no later than 5:00 p.m., New York City time, on such Settlement

Date, by wire transfer of immediately available funds to an account designated by the Sales Agent.

(c)[Reserved].

(d)Under

no circumstances shall the Company cause or request the offer or sale of any Placement Shares if, after giving effect to the sale of such

Placement Shares, the aggregate number or gross sales proceeds of Placement Shares sold pursuant to this Agreement would exceed the lesser

of (i) together with all sales of Placement Shares under this Agreement, the Maximum Amount, (ii) the amount available for offer

and sale under the then-effective Registration Statement and (iii) the amount authorized from time to time to be issued and sold

under this Agreement by the Company’s board of directors or a duly authorized committee thereof, and notified to the Sales Agent

in writing. Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares pursuant to this Agreement

at a price lower than the minimum price authorized from time to time by the Company’s board of directors or a duly authorized committee

thereof, and notified to the Sales Agent in writing. Notwithstanding anything to the contrary contained herein, the parties hereto acknowledge

and agree that compliance with the limitations set forth in this Section 5(d) on the number or dollar amount of Placement Shares that

may be issued and sold under this Agreement from time to time shall be the sole responsibility of the Company, and the Sales Agent shall

have no obligation in connection with such compliance.

(e)The

Company agrees that any offer to sell, any solicitation of an offer to buy, or any sales of Placement Shares or any other equity security

of the Company shall only be effected by or through a Sales Agent; provided however that (i) the foregoing limitation shall not apply

to (A) exercise of any option, warrant, right or any conversion privilege set forth in the instruction governing such securities, (B)

sales solely to employees, directors or security holders of the Company or its subsidiaries, or to a trustee or other person acquiring

such securities for the accounts of such person and (ii) such limitation shall not apply (A) on any day during which no sales are made

pursuant to this Agreement or (B) during a period in which the Company has notified the Agents that it will not sell Common Stock under

this Agreement and (1) no Placement Notice is pending or (2) after a Placement Notice has been withdrawn.

6.Representations

and Warranties of the Company

The Company represents, warrants

and covenants to the Sales Agent that as of the date of this Agreement and as of each Applicable Time (as defined below), unless such

representation, warranty or covenant specifies a different date or time:

(a)The

Company and the transactions contemplated by this Agreement meet the requirements for and comply with the conditions for the use of Form

S-3 (including General Instructions I.A and I.B.1.) under the Act. The Registration Statement has been filed with the Commission and has

been declared effective by the Commission under the Act prior to the issuance of any Placement Notice by the Company. The Prospectus Supplement

will name the Sales Agent as the agent engaged by the Company in the section entitled “Plan of Distribution.” The Registration

Statement and the offer and sale of Placement Shares as contemplated hereby meet the requirements of Rule 415 under the Rules and

Regulations and comply in all material respects with such Rule. The Company has not received, and has no notice from the Commission of,

any notice pursuant to Rule 401(g)(1) under the Act objecting to the use of the shelf registration statement form. Any statutes, regulations,

contracts or other documents that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits

to the Registration Statement have been so described or filed. Copies of the Registration Statement, the Prospectus and any such amendments

or supplements and all documents incorporated by reference therein that were filed with the Commission on or prior to the date of this

Agreement have been delivered to the Sales Agent and its counsel, or are available through EDGAR. The Company has not distributed and,

prior to the later to occur of each Settlement Date and completion of the distribution of the Placement Shares, will not distribute any

offering material in connection with the offering or sale of the Placement Shares other than the Registration Statement and the Prospectus

and any Issuer Free Writing Prospectus to which the Sales Agent has consented.

(b)No

order preventing or suspending the use of any Prospectus Supplement, the Prospectus or any Issuer Free Writing Prospectus has been issued

by the Commission, and no stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto

has been issued, and no proceeding for that purpose has been initiated or threatened by the Commission. On the date the Registration Statement

became effective (the “Effective Date”), on the date any Prospectus Supplement, the Prospectus, any Issuer Free Writing Prospectus

or any amendment or supplement thereto was or is filed with the Commission pursuant to the Act or the Exchange Act, at each Applicable

Time and at all times during the period through and including any Settlement Date and when any post-effective amendment to the Registration

Statement becomes effective, the Registration Statement, the Prospectus and any Issuer Free Writing Prospectus (in each case, as amended

or as supplemented, if applicable), including the financial statements, if any, included or incorporated by reference therein, did and

will comply in all material respects with all applicable requirements of the Act, the Exchange Act, the Exchange Act Rules and Regulations

and the Rules and Regulations, and did and will contain all statements required to be stated therein in accordance with the Act, the Exchange

Act, the Exchange Act Rules and Regulations and the Rules and Regulations. There are no contracts or other documents that are required

under the Act to be filed as exhibits to the Registration Statement that are not so filed.

When it became, becomes or

is deemed to become effective, no part of the Registration Statement or any amendment or supplement thereto did, does or will contain

an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements

therein not misleading. The Prospectus and any amendment and supplement thereto, as of its date and at each Applicable Time, did not,

does not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements

therein, in the light of the circumstances under which they were made, not misleading. Each Issuer Free Writing Prospectus, as of its

issue date and as of each Applicable Time, did not, does not and will not include any information that conflicted, conflicts or will conflict

with the information contained in the Registration Statement or the Prospectus, including any document incorporated by reference therein

that has not been superseded or modified.

As used in this subsection

and elsewhere in this Agreement:

“Applicable Time”

means (i) each Representation Date (as defined below), (ii) the time of each sale of any Placement Shares pursuant to this Agreement and

(iii) each Settlement Date.

“Issuer Free Writing

Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433 of the Rules and Regulations (“Rule

433”), relating to the Placement Shares that (i) is required to be filed with the Commission by the Company or (ii) is exempt from

filing pursuant to Rule 433(d)(5)(i), in each case, in the form filed or required to be filed with the Commission or, if not required

to be filed, in the form retained in the Company’s records pursuant to Rule 433(g).

The foregoing representations

and warranties in this Section 6(b) do not apply to any statements or omissions made in reliance on, and in conformity with, information

relating to the Sales Agent furnished in writing to the Company by the Sales Agent specifically for inclusion in the Registration Statement,

the Prospectus Supplement, the Prospectus or any Issuer Free Writing Prospectus, or any amendment or supplement thereto. The Company acknowledges

that the statements set forth in the 11th paragraph under the caption “Plan of Distribution” in the Prospectus

Supplement (the “Sales Agent Information”) constitute the only information relating to the Sales Agent furnished in writing

to the Company by the Sales Agent specifically for inclusion in the Registration Statement, the Prospectus Supplement, the Prospectus

and any Issuer Free Writing Prospectus.

(c)In

connection with the offering of the Placement Shares, (i) at the times specified in Rule 164 and Rule 433 of the Rules and Regulations

and (ii) as of the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 of the Rules

and Regulations (“Rule 405”)), without taking account of any determination by the Commission pursuant to Rule 405 that it

is not necessary that the Company be considered an ineligible issuer.

(d)The

Incorporated Documents, when they became or become effective or were or are filed with the Commission, as the case may be, complied or

will comply in all material respects with the requirements of the Act and the Exchange Act, as applicable, and the Rules and Regulations

and the Exchange Act Rules and Regulations, as applicable; and any further documents filed and incorporated by reference subsequent to

the Effective Date shall, when they are filed with the Commission, comply in all material respects with the requirements of the Act and

the Exchange Act, as applicable, and the Rules and Regulations and the Exchange Act Rules and Regulations, as applicable. Each Incorporated

Document did not, and any further documents filed and incorporated by reference therein will not, when filed with the Commission, contain

an untrue statement of a material fact or omit to state a material fact required to be stated in such document or necessary in order to

make the statements therein, in the light of the circumstances under which they were made, not misleading.

(e)Except

as otherwise disclosed, the Company does not own, directly or indirectly, any shares of stock or any other equity or long-term debt securities

of any corporation or have any equity interest in any corporation, firm, partnership, joint venture, association or other entity, other

than (i) the subsidiaries listed in Exhibit 21 to its most recent Annual Report on Form 10-K (collectively, the “Subsidiaries”),

(ii) those subsidiaries not required to be listed on Exhibit 21.1 by Item 601 of Regulation S-K under the Exchange Act, (iii) those subsidiaries

formed since the last day of the most recently ended fiscal year, and (iv) as disclosed in the Registration Statement and the Prospectus.

The Company and each of its Subsidiaries is duly organized, validly existing and in good standing under the laws of its jurisdiction of

organization. The Company and each of its Subsidiaries has full power and authority to conduct all the activities conducted by it, to

own or lease all the assets owned or leased by it and to conduct its business as described in the Registration Statement and the Prospectus.

The Company and each of its Subsidiaries is duly licensed or qualified to do business and in good standing as a foreign corporation or

such other entity in all jurisdictions in which the nature of the activities conducted by it or the character of the assets owned or leased

by it makes such license or qualification necessary, except to the extent that the failure to be so qualified or be in good standing could

not, individually or in the aggregate, have a material adverse effect or could reasonably be expected to have a material adverse effect

on the Company and its Subsidiaries, taken as a whole, or their respective assets, businesses, operations, earnings, properties, prospects,

conditions (financial or other), stockholders’ equity or results of operations, or prevent or materially interfere with consummation

of the transactions contemplated hereby (such effect is referred to herein as a “Material Adverse Effect”). All of the outstanding

shares of capital stock of each Subsidiary have been duly authorized and validly issued, are fully paid and nonassessable and free of

any preemptive or similar rights, and are wholly owned by the Company free and clear of all claims, liens, charges, security interests,

rights of first refusal and encumbrances; there are no securities outstanding that are convertible into or exercisable or exchangeable

for capital stock of any Subsidiary. The Company and its Subsidiaries are not engaged in any discussions or a party to any agreement or

understanding, written or oral, regarding the acquisition of an interest in any corporation, firm, partnership, joint venture, association

or other entity where such discussions, agreements or understandings would require disclosure in, or amendment to, the Registration Statement.

Complete and correct copies of the Amended and Restated Articles of Incorporation, as amended, (the “Certificate of Incorporation”)

and of the Second Amended and Restated By-laws of the Company (the “By-laws”) and the organizational documents of each of

its Subsidiaries and all amendments thereto have been delivered to the Sales Agent and its counsel, or are available through EDGAR.

(f)The

Company has authorized, issued and outstanding capital stock as set forth in, or incorporated by reference into, the Prospectus Supplement,

as of the respective date set forth therein (other than the grant of additional options under the Company’s existing stock option

plans, or changes in the number of outstanding shares of Common Stock of the Company due to the issuance of shares upon the exercise or

conversion of securities exercisable for, or convertible into, Common Stock outstanding on the date hereof) and such authorized capital

stock conforms in all material respects to the description thereof set forth in the Registration Statement and the Prospectus. All of

the outstanding shares of capital stock of the Company have been duly authorized, validly issued, are fully paid and nonassessable, were

issued in compliance in all material respects with all applicable state and federal securities laws and are not subject to any preemptive

rights, rights of first refusal or similar rights. The Placement Shares have been duly authorized and, when issued and delivered by the

Company against payment therefor as contemplated hereby, will be validly issued, fully paid and nonassessable, free and clear of any pledge,

lien, encumbrance, security interest or other claim, and will be registered pursuant to Section 12 of the Exchange Act; no preemptive

rights, rights of first refusal or similar rights exist with respect to any of the Placement Shares or the issue and sale thereof. The

description of the capital stock of the Company included or incorporated by reference in the Registration Statement, the Prospectus Supplement

and the Prospectus is complete and accurate in all material respects. The Placement Shares, when issued, will conform to the description

thereof set forth in or incorporated into the Prospectus. Except as set forth in the Prospectus Supplement and the Prospectus, the Company

does not have outstanding and will not have outstanding any options to purchase, or any rights or warrants to subscribe for, or any other

securities or obligations convertible into, or any other contracts or commitments to issue or sell, any shares of capital stock, or any

such warrants, convertible securities or obligations. The certificates evidencing the Placement Shares, if any, are in due and proper

legal form and have been duly authorized for issuance by the Company. The issuance and sale of the Placement Shares as contemplated hereby

will not cause any holder of any share capital, securities convertible into or exchangeable or exercisable for share capital or options,

warrants or other rights to purchase share capital or any other securities of the Company to have any right to acquire any preferred shares

or other securities of the Company.

(g)At

the time the Registration Statement was originally declared effective, and at the time the Company’s most recent Annual Report on

Form 10-K was filed with the Commission, the Company met the then-applicable requirements for the use of Form S-3 under the Act, including,

but not limited to, General Instruction I.B.1. of Form S-3. As of the date hereof, the Company meets the requirements for use of Form

S-3 under the Act specified in Conduct Rule 5110(h)(1) of the Financial Industry Regulatory Authority, Inc. (“FINRA”). The

aggregate market value of the outstanding voting and non-voting common equity (as defined in Rule 405) of the Company held by persons

other than affiliates of the Company (pursuant to Rule 144 of the Rules and Regulations, those that directly, or indirectly through one

or more intermediaries, control, or are controlled by, or are under common control with, the Company) (the “Non-Affiliate Shares”),

was equal to or greater than $75 million (calculated by multiplying (i) the highest price at which the common equity of the Company

closed on the Exchange within 60 days of the date of this Agreement by (ii) the number of Non-Affiliate Shares). The Company is not a

shell company (as defined in Rule 405) and has not been a shell company for at least 12 calendar months previously and if it has been

a shell company at any time previously, has filed current Form 10 information (as defined in Instruction I.B.6. of Form S-3) with the

Commission at least 12 calendar months previously reflecting its status as an entity that is not a shell company.

(h)The

financial statements, together with the related notes and schedules, included or incorporated by reference in the Registration Statement

or the Prospectus present fairly in all material respects the financial condition of the Company and its consolidated Subsidiaries as

of the respective dates thereof and the results of operations, cash flows and changes in stockholders’ equity of the Company and

its consolidated Subsidiaries for the respective periods covered thereby, all in conformity with generally accepted accounting principles

applied on a consistent basis throughout the entire period involved. No other financial statements or schedules (historical or pro forma)

are required by the Act, the Exchange Act, the Exchange Act Rules and Regulations or the Rules and Regulations to be included or incorporated

by reference in the Registration Statement or the Prospectus. To the extent applicable, any pro forma financial statements, information

or data included or incorporated by reference in the Registration Statement and the Prospectus comply with the requirements of Regulation

S-X of the Act, including, without limitation, Article 11 thereof, fairly present the information set forth therein in all material respects,

and the assumptions used in the preparation of such pro forma financial statements and data are reasonable, the pro forma adjustments

used therein are appropriate to give effect to the circumstances referred to therein and the pro forma adjustments have been properly

applied to the historical amounts in the compilation of those statements and data. MaloneBailey,

LLP (the “Accountant”), who have reported on the consolidated financial statements and schedules of the Company, are

and, during the periods covered by their report were, an independent registered public accounting firm with respect to the Company within

the meaning of, and as required by, the Act, the Rules and Regulations and the Public Company Accounting Oversight Board (United States)

(“PCAOB”). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of

the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) with respect to the Company. The other financial and statistical

data included and incorporated by reference in the Registration Statement and the Prospectus present accurately and fairly the information

shown therein and have been compiled on a basis consistent with the audited financial statements incorporated by reference in the Registration

Statement and the Prospectus and the books and records of the Company. All disclosures contained in the Registration Statement, the Prospectus

and any Issuer Free Writing Prospectus regarding “non-GAAP financial measures” (as such term is defined in the Rules and Regulations)

comply with Regulation G of the Exchange Act and Item 10(e) of Regulation S-K under the Act, to the extent applicable. The interactive

data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement and the Prospectus

fairly presents the information called for in all material respects and has been prepared in in all material respects in accordance with

the Commission’s rules and guidelines applicable thereto. The Prospectus delivered to Sales Agent for use in connection with the

sale of the Placement Shares pursuant to this Agreement will be identical to the versions of the Prospectus created to be transmitted

to the Commission for filing via EDGAR, except to the extent permitted by Regulation S-T.

(i)Except

as set forth in the Prospectus Supplement and the Prospectus, no person, as such term is defined in Rule 1-02 of Regulation S-X under

the Rules and Regulations (each, a “Person”), has the right, contractual or otherwise, to cause the Company to issue or sell

to such Person any Common Stock or shares of any other capital stock or other securities of the Company. No Person has any preemptive

rights, resale rights, rights of first refusal, rights of co-sale or any other rights (whether pursuant to a “poison pill”

provision or otherwise) to purchase any Common Stock or shares of any other capital stock or other securities of the Company. Except as

contemplated by this Agreement, no Person has the right to act as an underwriter or as a financial advisor to the Company in connection

with the offer and sale of the Placement Shares.

(j)Subsequent

to the respective dates as of which information is given in the Registration Statement and the Prospectus, (i) there has not been

any Material Adverse Effect, the occurrence of any development that the Company reasonably expects could result in a Material Adverse

Effect or any material adverse change, or any development that could reasonably be expected to result in a material adverse change, in

the general affairs, business, management, condition (financial or otherwise), earnings, results of operations, properties, operations,

assets, liabilities or prospects of the Company and its Subsidiaries, taken as a whole, whether or not arising from transactions in the

ordinary course of business (a “Material Adverse Change”), (ii) there has not been any change in the capitalization or long-term

indebtedness of the Company of the Company (other than in connection with the exercise of options to purchase the Common Stock granted

pursuant to the Company’s stock option plans from the shares reserved therefor as described in the Registration Statement and the

Prospectus, the exercise of warrants described in the Registration Statement and the Prospectus, and the grant of stock options in the

ordinary course of business and consistent with the past practice of the Company), (iii) neither the Company nor any of its Subsidiaries

has incurred, except in the ordinary course of business as described in the Prospectus, any material liabilities or obligations, direct

or contingent (including any off-balance sheet obligations), nor has the Company or any of its Subsidiaries entered into any material

transactions other than pursuant to this Agreement and the transactions referred to herein and (iv) the Company has not paid, made

or declared any dividends or other distributions of any kind on any class of its capital stock or the capital stock of any Subsidiary.

(k)The

Company and its Subsidiaries are not, will not become as a result of or after giving effect to the transactions contemplated hereby (including

the offer and sale of the Placement Shares), and will not conduct their business in a manner that would cause any of them to be, an “investment

company,” an entity “controlled” by an “investment company” or an “affiliated person” of, or

“promoter” or “principal underwriter” for, an “investment company,” as each such terms are defined

in the Investment Company Act of 1940, as amended.

(l)Neither

the issuance, sale and delivery of the Placement Shares nor the application of the proceeds thereof by the Company as described in the

Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or

any other regulation of such Board of Governors.

(m)Except

as set forth in the Registration Statement, the Pricing Prospectus and the Prospectus, there are no actions, suits or proceedings pending

or, to the knowledge of the Company, threatened against or affecting the Company, any of its Subsidiaries or any of its or their officers

in their capacity as such, nor any basis therefor, before or by any federal or state court, commission, regulatory body, administrative

agency or other governmental body, domestic or foreign, wherein an unfavorable ruling, decision or finding could have a Material Adverse

Effect. To the knowledge of the Company, there are no current or pending legal, governmental or regulatory audits or investigations, actions,

suits or proceedings that are required under the Act to be described in the Registration Statement or the Prospectus that are not so described.

(n)The

Company and each Subsidiary has and will have performed all the obligations required to be performed by it, and is not and will not be,

(i) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance

or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or any other contract,

agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries

is bound or to which any of the property or assets of the Company or any of its Subsidiaries are subject or (ii) in violation of

any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, which

default or violation, in the cases of clauses (i) or (ii), could reasonably be expected to have a Material Adverse Effect. To the knowledge

of the Company, no other party under any contract or other instrument to which it or any of its Subsidiaries is a party is in default

in any respect thereunder, which default could reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of

its Subsidiaries is or will be in violation of any provision of its certificate or articles of incorporation or by-laws or similar organizational

documents. Neither the Company nor any of its Subsidiaries has (i) failed to pay any dividend or sinking fund installment on preferred

stock or (ii) defaulted on any installment or other payment on indebtedness for borrowed money or on any rental on one or more long-term

leases, which defaults, individually or in the aggregate, could have a Material Adverse Effect.

(o)No

consent, approval, authorization or order of, or any filing or declaration with, any court, arbitrator or governmental or regulatory agency

or body is required for the consummation of the transactions contemplated hereby, except such as have been obtained under the Act or the

Rules and Regulations and such as may be required under state securities or Blue Sky laws, the by-laws and rules of FINRA or the Exchange

in connection with the sale of the Placement Shares by the Sales Agent.

(p)The

Company has full corporate power and authority to enter into this Agreement and perform the transactions contemplated hereby. This Agreement

has been duly authorized, executed and delivered by the Company and constitutes a legal, valid and binding agreement of the Company, enforceable

against the Company in accordance with the terms hereof. The execution and performance of this Agreement and the consummation of the transactions

contemplated hereby (including the issuance and sale of the Placement Shares) will not result in the creation or imposition of any lien,

charge or encumbrance upon any of the assets of the Company or any of its Subsidiaries pursuant to the terms or provisions of, or result

in a breach or violation of any of the terms or provisions of, or conflict with or constitute a default under, or give any party a right

to terminate any of its obligations under, or result in the acceleration of any obligation under, (i) the certificate or articles of incorporation

or by-laws or other organizational documents of the Company or any of its Subsidiaries, (ii) any indenture, mortgage, deed of trust, voting

trust agreement, loan agreement, bond, debenture, note agreement or other evidence of indebtedness, lease, contract or other agreement

or instrument to which the Company or any of its Subsidiaries is a party or by which the Company, any of its Subsidiaries or any of its

or their properties is bound or affected, or (iii) violate or conflict with any judgment, ruling, decree, order, statute, rule or regulation

of any court or other governmental agency or body applicable to the business or properties of the Company or any of its Subsidiaries,

which lien, charge, encumbrance, breach, violation, conflict, default, termination or acceleration, in the cases of clauses (ii) or (iii),

would have a Material Adverse Effect.

(q)The

Company and its Subsidiaries have good and marketable title in fee simple to all properties and assets described in the Registration Statement

and the Prospectus as owned by them, free and clear of all liens, charges, encumbrances, claims or restrictions, except such as are not

material to the business of the Company or its Subsidiaries. The Company and its Subsidiaries have valid, subsisting and enforceable leases

for the properties described in the Registration Statement and the Prospectus as leased by them. The Company and its Subsidiaries own

or lease all such properties as are necessary to their operations as now conducted or as proposed to be conducted, except where the failure

to so own or lease would not be reasonably expected to have a Material Adverse Effect. Each of the properties of the Company and its Subsidiaries

complies in all material respects with all applicable codes, laws and regulations (including, without limitation, building and zoning

codes, laws and regulations and laws relating to access to such properties), except for such failures to comply that could not, individually

or in the aggregate, reasonably be expected to interfere in any material respect with the use made and proposed to be made of such property

by the Company and its Subsidiaries or otherwise have a Material Adverse Effect. None of the Company or its Subsidiaries has received

from any governmental or regulatory authorities any notice of any condemnation of, or zoning change affecting, the properties of the Company

and its Subsidiaries, and the Company knows of no such condemnation or zoning change that is threatened, except for such that could not

reasonably be expected to interfere in any material respect with the use made and proposed to be made of such property by the Company

and its Subsidiaries or otherwise could have, individually or in the aggregate, a Material Adverse Effect.

(r)There

is no document, contract, permit or instrument, transaction, relationship, arrangement or off-balance sheet transaction (including, without

limitation, any structural finance, special purpose or limited purpose entity or any “variable interests” in “variable

interest entities,” as such terms are defined in Financial Accounting Standards Board Interpretation No. 46, as codified in Accounting

Standards Codification Topic 810) of a character required to be described in the Registration Statement or the Prospectus or to be filed

as an exhibit to the Registration Statement that is not described or filed as required. All contracts to which the Company or any of its

Subsidiaries is a party that are described in, or filed with, the Registration Statement or the Prospectus have been duly authorized,

executed and delivered by the Company or such Subsidiary, constitute valid and binding agreements of the Company or such Subsidiary and

are enforceable against and by the Company or such Subsidiary in accordance with the terms thereof.

(s)None

of the Company, any of its Subsidiaries or any of their respective directors, officers or controlling persons has taken, directly or indirectly,

any action designed, or that might reasonably be expected to cause or result, under the Exchange Act or otherwise, in, or that has constituted,

stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.

(t)No

holder of securities of the Company has rights, contractual or otherwise, to require the Company to register any securities pursuant to

the Registration Statement, or to include any securities in the Registration Statement or the offering contemplated thereby, whether as

a result of the filing or effectiveness of the Registration Statement, the sale of the Placement Shares as contemplated hereby or otherwise,

which rights have not been duly waived in a writing furnished to the Sales Agent by the holder thereof as of the date hereof.

(u)The

Common Stock is registered under Section 12(b) of the Exchange Act and is currently listed on the Exchange under the trading symbol “NEOV.”

There is no action pending by the Company or, to the Company’s knowledge, by the Exchange designed to, or likely to have the effect

of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Exchange, nor has the

Company received any notification that the Commission or the Exchange is contemplating terminating such registration or listing. The Company

is in compliance in all material respects with all applicable listing requirements of the Exchange.

(v)(i) The

Company and each of its Subsidiaries owns or has adequate rights to use all trademarks, trade names, domain names, patents, patent rights,

mask works, copyrights, technology, know-how (including trade secrets and other unpatented or unpatentable proprietary or confidential

information, systems or procedures), service marks, trade dress rights and other intellectual property and registrations and applications

for registration for any of the foregoing (collectively, “Intellectual Property”) and has such other licenses, approvals and

governmental authorizations, in each case, sufficient to conduct its business as now conducted and as now proposed to be conducted, and,

to the Company’s and its Subsidiaries’ knowledge, there are no rights of third parties to any such Intellectual Property owned

by the Company and its Subsidiaries and none of the foregoing Intellectual Property rights owned or licensed by the Company or any of

its Subsidiaries is invalid or unenforceable, (ii) the Company has no knowledge of any infringement by it or any of its Subsidiaries

of Intellectual Property rights of others, and there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding

or claim by others that the Company and its Subsidiaries infringe or otherwise violate any Intellectual Property rights of others, where

such infringement or violation could have a Material Adverse Effect, (iii) the Company is not aware of any infringement, misappropriation

or violation by others of, or conflict by others with rights of the Company or any of its Subsidiaries with respect to, any Intellectual

Property, (iv) there is no suit, proceeding or claim being made against the Company or any of its Subsidiaries or, to the knowledge

of the Company and its Subsidiaries, any employee of the Company or any of its Subsidiaries, regarding Intellectual Property, challenging

the Company’s and its Subsidiaries’ rights in or to any such Intellectual Property or alleging other infringement that could

have a Material Adverse Effect, and the Company is unaware of any facts which could form a reasonable basis for any such action, suit,

proceeding or claim, (v) to the Company’s knowledge, there is no third-party U.S. patent or published U.S. patent application that

contains claims for which an “interference proceeding” (as defined in 35 U.S.C. § 135) has been commenced against any

patent or patent application described in the Prospectus as being owned by or licensed to the Company and (vi) the Company and its Subsidiaries

have not received any notice of infringement with respect to any patent or any notice challenging the validity, scope or enforceability

of any Intellectual Property owned by or licensed to the Company or any of its Subsidiaries, in each case the loss of which patent or

Intellectual Property (or loss of rights thereto) would be reasonably expected to have a Material Adverse Effect. The Company and its

Subsidiaries have taken all reasonable steps necessary to secure their interests in such Intellectual Property from their employees and

contractors (including, but not limited to, assignments of such Intellectual Property from such employees and contractors) and to protect

the confidentiality of all of their confidential information and trade secrets and that of third parties in their possession to the extent

contractually required to do so.

(w)None

of the Intellectual Property or technology (including information technology and outsourced arrangements) employed by the Company or the

Subsidiaries has been obtained or is being used by the Company or the Subsidiaries in violation of any contractual obligation binding

on the Company or any of the Subsidiaries or, to the knowledge of the Company and its Subsidiaries, any of their respective officers,

directors or employees, where such violation or violation could have a Material Adverse Effect. The Company and the Subsidiaries own or

have a valid right to access and use all computer systems, networks, hardware, software, databases, websites and equipment used to process,

store, maintain and operate data, information and functions used in connection with the business of the Company and the Subsidiaries (the

“Company IT Systems”). The Company IT Systems are adequate for, and operate and perform in all material respects as required

in connection with, the operation of the business of the Company and the Subsidiaries as currently conducted free and clear of all material

bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants, except as would not be reasonably expected to have a

Material Adverse Effect. The Company and its subsidiaries have implemented and maintained commercially reasonable controls, policies,

procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy

and security of all Company IT Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated

data (“Personal Data”)) used in connection with their businesses, and except as would not have a Material Adverse Effect,

there have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied

without material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating

to the same. The Company and its subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments,

orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations

relating to the privacy and security of Company IT Systems and Personal Data and to the protection of such Company IT Systems and Personal

Data from unauthorized use, access, misappropriation or modification.

(x)The

Company and each of its Subsidiaries have filed all federal, state, local and foreign tax returns that have been required to be filed

and has paid all taxes and assessments shown thereon to the extent that such taxes or assessments have become due. Neither the Company

nor any of its Subsidiaries has any tax deficiency, penalty or assessment that has been or, to the knowledge of the Company, might be

asserted or threatened against it that could have a Material Adverse Effect. On each Settlement Date, all stock transfer or other taxes

(other than income taxes) that are required to be paid in connection with the sale and transfer of the Placement Shares to be sold hereunder

will be, or will have been, fully paid or provided for by the Company and all laws imposing such taxes will be or will have been fully

complied with.

(y)The

Company and its Subsidiaries own or possess all authorizations, approvals, orders, licenses, registrations, other certificates and permits

of and from all governmental regulatory officials and bodies, necessary to conduct their respective businesses as contemplated in the

Registration Statement and the Prospectus, except where the failure to own or possess all such authorizations, approvals, orders, licenses,

registrations, other certificates and permits would not be reasonably expected to have a Material Adverse Effect. There is no proceeding

pending or threatened (or any basis therefor known to the Company) that may cause any such authorization, approval, order, license, registration,

other certificate or permit to be revoked, withdrawn, cancelled, suspended or not renewed; and the Company and each of its Subsidiaries

is conducting its business in compliance in all material respects with all laws, rules and regulations applicable thereto (including,

without limitation, all applicable federal, state and local environmental laws and regulations); the Company has not received a notice

of non-compliance, nor knows of, nor has reasonable grounds to know of, any facts that could give rise to a notice of non-compliance with

any such laws, rules and regulations, and is not aware of any pending change or contemplated change to any applicable laws, rules and

regulations or governmental positions; in each case that would materially adversely affect the business of the Company or the business

or legal environment under which the Company operates.

(z)The

Company and each of its Subsidiaries maintains or is covered by insurance of the types and in the amounts reasonably deemed adequate for

its business and customary for companies engaged in similar businesses in similar industries, including, but not limited to, insurance

covering real and personal property owned or leased by the Company and its Subsidiaries against theft, damage, destruction, acts of vandalism

and all other risks customarily insured against, all of which insurance is in full force and effect.

(aa)Other than as contemplated

by this Agreement, the Company has not incurred and will not incur any liability for any finder’s or broker’s fee or agent’s

commission in connection with the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby.

(bb)The Company is in

compliance in all material respects with, and there has been no failure on the part of the Company or any of the Company’s directors

or officers, in their capacities as such, to comply with, all applicable provisions of the Sarbanes-Oxley Act and the rules and regulations

of the Commission thereunder. Each of the principal executive officer and the principal financial officer of the Company (or each former

principal executive officer of the Company and each former principal financial officer of the Company, as applicable) has made all certifications

required by Sections 302 and 906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements and other documents

required to be filed or furnished to the Commission. For purposes of the preceding sentence, “principal executive officer”

and “principal financial officer” shall have the meanings given to such terms in the Sarbanes-Oxley Act.

(cc)Neither the Company

nor any of its Subsidiaries nor, to the best of the Company’s knowledge, any director, officer, agent, employee or other person

associated with or acting on behalf of the Company or any of its Subsidiaries has, directly or indirectly, (i) used any corporate funds

for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity, (ii) made any unlawful payment

from corporate funds to any foreign or domestic government official or employee or foreign or domestic political party or campaign, (iii)

violated any provision of the Foreign Corrupt Practices Act of 1977 or any comparable applicable law in another jurisdiction, or (iv)

made any bribe, illegal rebate, payoff, influence payment, kickback or other unlawful payment. The Company, its Subsidiaries and each

of their respective affiliates have instituted and maintain, and will continue to maintain, policies and procedures designed to ensure,

and which are reasonably expected to continue to ensure, continued compliance therewith.

(dd)The books, records

and accounts of the Company and its Subsidiaries accurately and fairly reflect, in reasonable detail, the transactions in, and dispositions

of, the assets of, and the results of operations of, the Company and its Subsidiaries. The Company and each of its Subsidiaries maintains

a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance

with management’s general or specific authorization, (ii) transactions are recorded as necessary to permit preparation of the

Company’s consolidated financial statements in accordance with generally accepted accounting principles and to maintain asset accountability,

(iii) access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the

recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect

to any differences. Except as set forth in the Prospectus Supplement and the Prospectus, the Company’s internal control over financial

reporting is effective and the Company is not aware of any material weaknesses in its internal control over financial reporting. Except

as set forth in the Prospectus Supplement and the Prospectus, since the date of the latest audited financial statements included or incorporated

by reference in the Prospectus, there has been no change in the Company’s internal control over financial reporting that has materially

affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

(ee)The Company has established

and maintains disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)); such disclosure controls and procedures

have been designed to ensure that material information relating to the Company and its Subsidiaries is made known to the Company’s

principal executive officer and principal financial officer by others within those entities, particularly during the period in which the

Company’s Annual Report on Form 10-K or Quarterly Report on Form 10-Q, as the case may be, is being prepared. The Company’s

certifying officers have evaluated the effectiveness of the Company’s disclosure controls and procedures as of a date within 90

days prior to the filing date of the Form 10-K for the most recently ended fiscal year (such date, the “Evaluation Date”).

The Company presented in its Form 10-K for the most recently ended fiscal year the conclusions of the certifying officers about the effectiveness

of the disclosure controls and procedures based on their evaluations as of the Evaluation Date and the disclosure controls and procedures

are effective. Except as set forth in the Prospectus Supplement and the Prospectus, since the Evaluation Date, there have been no significant

changes in the Company’s disclosure controls or, to the Company’s knowledge, in other factors that could significantly affect

the Company’s disclosure controls.

(ff)There are no affiliations

or associations between any member of FINRA and any of the Company’s officers, directors or, to the knowledge of the Company, any

5% or greater securityholders, except as set forth in the Registration Statement and the Prospectus. Neither the Company nor any of the

Subsidiaries (i) is required to register as a “broker” or “dealer” in accordance with the provisions of the

Exchange Act or (ii) directly or indirectly through one or more intermediaries, controls or is a “person associated with a

member” or “associated person of a member” (within the meaning set forth by FINRA).

(gg)Neither the Company

nor any of its Subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee, affiliate or representative

of the Company or any of its Subsidiaries is a government, individual or entity that is, or is owned or controlled by an individual or

entity that is (i) the subject of any sanctions administered or enforced by the Office of Foreign Assets Control of the U.S. Treasury

Department, the United Nations Security Council, the European Union, His Majesty’s Treasury or other relevant sanctions authority

(“Sanctions”), nor (ii) located, organized or resident in a country or territory that is the subject of Sanctions (currently,

Cuba, Iran, North Korea, Russia, the Crimea, the Donetsk, Luhansk, Zaporizhzhia and Kherson regions of Ukraine, Afghanistan, the Balkans,

Belarus, Burma, Central African Republic, the Democratic Republic of Congo, Ethiopia, Hong Kong, Iraq, Lebanon, Libya, Mali, Nicaragua,

Somalia, South Sudan, Sudan, Venezuela and Yemen). The Company and its Subsidiaries have not engaged in, and are not now engaged in, and

will not engage in any dealings or transactions with any government, individual or entity, or in any country or territory, that at the

time of the dealing or transaction is or was the subject of Sanctions, and have instituted and maintain policies and procedures designed

to promote and achieve compliance with such Sanctions. The Company and its Subsidiaries will not, directly or indirectly, use the proceeds

of the issuance and sale of the Placement Shares, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint

venture partner or other person (A) to fund or facilitate any activities or business of or with any government, individual

or entity or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions; or (B) in

any other manner that will result in a violation of Sanctions by any government, individual or entity (including any government, individual

or entity participating in the offering, whether as underwriter, advisor, investor or otherwise).

(hh)The operations of

the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting

requirements of the Currency and Foreign Transactions Reporting Act of 1970, the money laundering laws of all applicable jurisdictions,

the rules and regulations thereunder and any related or similar rules, regulations or guidelines administered or enforced by any applicable

governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or

governmental agency, authority or body or any arbitrator involving the Company or any of its Subsidiaries with respect to the Money Laundering

Laws is pending or, to the knowledge of the Company, threatened.

(ii)Except

as would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect, (i) each of the Company and

each of its Subsidiaries (A) is in compliance with all applicable rules, laws and regulation relating to pollution, the protection of

health or the environment, and the use, transportation, treatment, storage and disposal of, or exposure to, hazardous or toxic substances

or wastes, (“Environmental Law”) and (B) has received and is in compliance with all permits, licenses or other approvals required

of them under applicable Environmental Law to conduct their respective businesses as described in the Registration Statement and the Prospectus,

(ii) none of the Company nor any of its Subsidiaries has received any notice from any governmental authority or third party, or otherwise

has knowledge, of any asserted claim under Environmental Laws, and (iii) no facts currently exist that could subject the Company or any

of its Subsidiaries to liability under Environmental Laws, including any liability for remediation of any releases or threatened releases

of hazardous or toxic substances.

(jj)The statistical, industry-related

and market-related data included or incorporated by reference in the Registration Statement and the Prospectus are based on or derived

from sources the Company reasonably and in good faith believes are reliable and accurate, and such data agrees with the sources from which

they are derived, and the Company has obtained the written consent to the use of such data from such sources to the extent required.

(kk)The Company and each

of its Subsidiaries is in compliance in all material respects with all applicable provisions of the Employee Retirement Income Security

Act of 1974, including the regulations and published interpretations thereunder (“ERISA”); no “reportable event”

(as defined in ERISA) has occurred with respect to any “pension plan” (as defined in ERISA) for which the Company and each

of its Subsidiaries would have any liability; each of the Company and each of its Subsidiaries has not incurred and does not expect to

incur liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any “pension plan” or (ii)

Sections 412 or 4971 of the Internal Revenue Code of 1986, including the regulations and published interpretations thereunder (the “Code”);

and each “pension plan” for which the Company or any Subsidiary would have any liability that is intended to be qualified

under Section 401(a) of the Code is so qualified in all material respects and nothing has occurred, whether by action or by failure to

act, which would cause the loss of such qualification.

(ll)No material labor

dispute with the employees of the Company or any of its Subsidiaries exists or, to the knowledge of the Company, is imminent; and the

Company is not aware of any existing, threatened or imminent labor disturbance by the employees of any of its principal suppliers, manufacturers

or contractors that could have a Material Adverse Effect.

(mm)No Subsidiary is currently

prohibited, directly or indirectly, from paying any dividends to the Company, from making any other distribution on such Subsidiary’s

capital stock, from repaying to the Company any loans or advances to such Subsidiary from the Company or from transferring any of such

Subsidiary’s property or assets to the Company or any other Subsidiary of the Company.

(nn)The Company and its

Subsidiaries have operated its business in a manner compliant in all material respects with all privacy and data protection laws and regulations

applicable to the Company’s and its Subsidiaries’ collection, handling, and storage of its customers’ data. The Company

and its Subsidiaries have policies and procedures in place designed to ensure the integrity and security of the data collected, handled

or stored in connection with the delivery of its product offerings. The Company and its Subsidiaries comply with, have policies and procedures

in place designed to ensure privacy and data protection laws are complied with and takes appropriate steps which are reasonably designed

to assure compliance in all material respects with such policies and procedures.

(oo)No

forward-looking statement (within the meaning of Section 27A of the Act and Section 21E of the Exchange Act) contained in the Registration

Statement and the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.

(pp)The Company is not

a party to any agreement with an agent or underwriter for any other “at the market” or continuous equity transaction.

(qq)The Company acknowledges

and agrees that Sales Agent has informed the Company that the Sales Agent may, to the extent permitted under the Act and the Exchange

Act, purchase and sell Common Stock for its own account while this Agreement is in effect, provided, that (i) no such purchase

or sales shall take place while a Placement Notice is in effect (except to the extent the Sales Agent may engage in sales of Placement

Shares purchased or deemed purchased from the Company as a “riskless principal” or in a similar capacity) and (ii) the

Company shall not be deemed to have authorized or consented to any such purchases or sales by the Sales Agent.

(rr)No statement, representation,

warranty or covenant made by the Company in this Agreement or made in any certificate or document required by this Agreement to be delivered

to the Sales Agent was or will be, when made, inaccurate, untrue or incorrect.

Any certificate signed by

an officer of the Company and delivered to the Sales Agent or to counsel for the Sales Agent pursuant to or in connection with this Agreement

shall be deemed to be a representation and warranty by the Company, as applicable, to the Sales Agent as to the matters set forth therein.

7.Agreements

of the Company.

The Company covenants

and agrees with the Sales Agent as follows:

(a)The

Company will not, either prior to the first Applicable Time or thereafter during such period as the Prospectus is required by law to be

delivered in connection with sales of the Placement Shares by the Sales Agent or a dealer, file any amendment, supplement or other document

under the Exchange Act or the Exchange Act Rules and Regulations relating to the Placement Shares or a security convertible into the Placement

Shares, if such document would be deemed to be incorporated by reference into the Registration Statement or the Prospectus, unless a copy

thereof shall first have been submitted to the Sales Agent for approval within a reasonable period of time prior to the filing thereof

(provided, however, that the failure of the Company to obtain the Sales Agent’s approval shall not relieve the Company

of any obligation or liability hereunder, or affect the Sales Agent’s right to rely on the representations and warranties made by

the Company in this Agreement).

(b)So

long as delivery of the Prospectus relating to any Placement Shares may be required to be delivered by the Sales Agent or any dealer under

the Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 of the Rules and Regulations or any similar

rule), the Company will notify the Sales Agent promptly, and will confirm such advice in writing, (i) when any amendment to the Registration

Statement has been filed or becomes effective or any amendment or supplement to the Prospectus has been filed, in each case, other than

documents incorporated by reference, (ii) of any request by the Commission for amendments or supplements to the Registration Statement

or the Prospectus or for additional information related to the offering of the Placement Shares or to the Registration Statement, the

Prospectus or any Issuer Free Writing Prospectus, (iii) of its receipt of notice or its knowledge of the issuance or threatened issuance

by the Commission of any stop order suspending the effectiveness of the Registration Statement or preventing or suspending the use of

the Prospectus Supplement, the Prospectus or any Issuer Free Writing Prospectus or the initiation of any proceedings for that purpose

or the threat thereof, (iv) of the suspension of the qualification of the Placement Shares for offering and sale in any jurisdiction,

or the initiation or threatening of any proceeding for that purpose, and (v) of receipt by the Company or any representative or counsel

to the Company of any other communication from the Commission relating to the Company, the Registration Statement, the Prospectus Supplement,

the Prospectus or the issuance and sale of the Placement Shares. If at any time the Commission shall issue any order suspending the effectiveness

of the Registration Statement or preventing or suspending the use of the Prospectus Supplement, the Prospectus or any Issuer Free Writing

Prospectus, the Company will make every reasonable effort to obtain the withdrawal of such order at the earliest possible moment. If the

Company has omitted any information from the Registration Statement pursuant to Rule 430B of the Rules and Regulations, the Company will

comply with the provisions of and make all requisite filings with the Commission pursuant to said Rule 430B and notify the Sales Agent

promptly of all such filings. The Company will cause each amendment or supplement to the Prospectus to be filed with the Commission as

required pursuant to the applicable paragraph of Rule 424(b) of the Act or, in the case of any document to be incorporated by reference

therein, to be filed with the Commission as required pursuant to the Exchange Act, within the time period prescribed. If the Company elects

to rely upon Rule 462(b) under the Act, the Company shall file a registration statement under Rule 462(b) with the Commission in compliance

with Rule 462(b) by 10:00 p.m., Washington, D.C. time, on the date of this Agreement, and the Company shall at the time of filing either

pay to the Commission the filing fee for such Rule 462(b) registration statement or give irrevocable instructions for the payment of such

fee pursuant to the Rules and Regulations. So long as delivery of the Prospectus relating to any Placement Shares may be required to be

delivered by the Sales Agent or any dealer under the Act (including in circumstances where such requirement may be satisfied pursuant

to Rule 172 of the Rules and Regulations or any similar rule), the Company will comply with all requirements imposed upon it by the Act,

as from time to time in force, and to file on or before their respective due dates all reports and any definitive proxy or information

statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision

of or under the Exchange Act.

(c)The

Company will furnish to the Sales Agent, without charge, written and electronic copies of each of the Registration Statement and of any

pre- or post-effective amendment thereto, including financial statements and schedules, and all exhibits thereto, the Prospectus (including

all documents incorporated by reference therein), the Prospectus Supplement, each Issuer Free Writing Prospectus and all amendments and

supplements thereto that are filed with the Commission during any period that a Prospectus relating to the Placement Shares is required

to be delivered under the Act, in each case as soon as reasonably practicable and in such quantities as the Sales Agent may from time

to time reasonably request and, at the Sales Agent’s request, will also furnish copies of the Prospectus to each exchange or market

on which sales of the Placement Shares may be made; provided, however, that the Company shall not be required to furnish

any document (other than the Prospectus) to the Sales Agent to the extent such document is available on EDGAR.

(d)The

Company will use its best efforts to comply with all requirements imposed upon it by the Act and the Exchange Act as from time to time

in force, so far as necessary to permit the sales of, or dealings in, the Placement Shares as contemplated by the provisions hereof and

the Prospectus.

(e)So

long as delivery of the Prospectus relating to any Placement Shares may be required to be delivered by the Sales Agent or any dealer under

the Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 of the Rules and Regulations or any similar

rule), the Company will prepare and file with the Commission, promptly upon the Sales Agent’s request, any amendments or supplements

to the Registration Statement or the Prospectus that, in the Sales Agent’s reasonable opinion, may be necessary or advisable in

connection with the distribution of the Placement Shares by the Sales Agent (provided, however, that the failure of the

Sales Agent to make such request shall not relieve the Company of any obligation or liability hereunder, or affect the Sales Agent’s

right to rely on the representations and warranties made by the Company in this Agreement). The Company consents to the use of the Prospectus

Supplement, the Prospectus, each Issuer Free Writing Prospectus and any amendment or supplement thereto by the Sales Agent and by all

dealers to whom the Placement Shares may be sold, both in connection with the offering or sale of the Placement Shares and for any period

of time thereafter during which the Prospectus is required by law to be delivered in connection therewith. If during such period of time

any event shall occur that in the judgment of the Company or counsel to the Sales Agent should be set forth in the Prospectus in order

to make any statement therein, in the light of the circumstances under which it was made, not misleading, or if it is necessary to supplement

or amend the Prospectus to comply with law, the Company will notify the Sales Agent to suspend the offering of Placement Shares during

such period and the Company will forthwith prepare and duly file with the Commission an appropriate supplement or amendment thereto, and

will deliver to the Sales Agent, without charge, such number of copies of such supplement or amendment to the Prospectus as the Sales

Agent may reasonably request. If at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event

or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in

the Registration Statement, the Prospectus Supplement or the Prospectus or included or would include an untrue statement of a material

fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances

prevailing at that subsequent time, not misleading, the Company will promptly notify the Sales Agent and, if requested by the Sales Agent,

will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue

statement or omission.

(f)The

Company will use its reasonable best efforts and cooperate with the Sales Agent in connection with the registration or qualification of

the Placement Shares for offer and sale under the state or foreign securities or Blue Sky laws of such jurisdictions as the Sales Agent

may request and to maintain such registration or qualification in effect for so long as required for the distribution of the Placement

Shares (but in no event for less than one year from the date of this Agreement); provided, that in no event shall the Company be

obligated to qualify to do business in any jurisdiction where it is not now so qualified or to take any action that would subject it to

general service of process in any jurisdiction where it is not now so subject. In each applicable jurisdiction, the Company will file

such statements and reports as may be required by the laws of such jurisdiction to continue such registration or qualification in effect

for so long as required for the distribution of the Placement Shares (but in no event for less than one year from the date of this Agreement).

(g)The

Company will, so long as required under the Rules and Regulations, furnish to its stockholders as soon as practicable after the end of

each fiscal year an annual report (including a balance sheet and statements of income, stockholders’ equity and cash flow of the

Company and its consolidated Subsidiaries, if any, certified by independent public accountants) and, as soon as practicable after the

end of each of the first three quarters of each fiscal year (beginning with the fiscal quarter ending after the Effective Date), consolidated

summary financial information of the Company and its Subsidiaries, if any, for such quarter in reasonable detail.

(h)The

Company will make generally available to holders of its securities as soon as practicable, but in no event later than 15 months after

the end of the Company’s current fiscal quarter, an earning statement covering a period of 12 months that satisfies the provisions

of Section 11(a) of the Act (including Rule 158 of the Rules and Regulations).

(i)Whether

or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or reimburse

if paid by the Sales Agent all costs and expenses incident to the performance of the obligations of the Company under this Agreement and

in connection with the transactions contemplated hereby, including but not limited to costs and expenses of or relating to (i) the

preparation, printing and filing of the Registration Statement and exhibits to it, the Prospectus Supplement, the Prospectus, any Issuer

Free Writing Prospectus and any amendment or supplement to any of the foregoing, including any fees required by the Commission in connection

therewith, (ii) the preparation and delivery of certificates, if any, representing the Placement Shares, including any stock or other

transfer taxes and any capital duties, stamp duties or other duties or taxes payable upon the sale, issuance or delivery of the Placement

Shares to the Sales Agent, (iii) furnishing (including costs of shipping and mailing) such copies of the Registration Statement, the Prospectus

Supplement, the Prospectus and any Issuer Free Writing Prospectus, and all amendments and supplements thereto, as may be requested by

the Sales Agent for use in connection with the offering and sale of the Placement Shares, (iv) the listing of the Placement Shares

on the Exchange, (v) any filings required to be made in connection with clearance of the offering of the Placement Shares with FINRA

(including the fees, disbursements and other charges of counsel for the Sales Agent in connection therewith), (vi) the registration

or qualification of the Placement Shares for offer and sale under state or foreign securities or Blue Sky laws and the preparation, printing

and distribution of any Blue Sky memoranda (including the fees, disbursements and other charges of counsel to the Sales Agent in connection

therewith), (vii) fees, disbursements and other charges of counsel to the Company and of the Accountant, (viii) the transfer

agent for the Placement Shares and (ix) all other costs and expenses of the Sales Agent incident to the performance of its obligations

hereunder not otherwise specifically provided for herein, including the fees, disbursements and other charges of counsel to the Sales

Agent (in addition to those set forth in clauses (v) and (vi)); provided, however, that in no event under this clause (x)

shall the Company be required to pay or reimburse any Sales Agent costs and expenses in excess of $100,000 in connection with the establishment

of the ATM Program (to be paid at the time of the initial sale of Placement Shares hereunder) and $10,000 for each periodic update of

the ATM Program.

(j)The

Company will not at any time, directly or indirectly, (i) take any action designed or that might reasonably be expected to cause or result

in, or that will constitute, stabilization of the price of the shares of Common Stock to facilitate the sale or resale of any of the Placement

Shares or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases

of the Placement Shares other than the Sales Agent. The Company will promptly notify the Sales Agent upon the occurrence of any event

or development that would result in the Placement Shares losing the exemption from the restrictions of Regulation M.

(k)The

Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor any of its Subsidiaries will be or become,

at any time prior to the termination of this Agreement, required to register as an “investment company,” as such term is defined

in the Investment Company Act.

(l)The

Company will use the Net Proceeds in the manner set forth in the Prospectus under the caption “Use of Proceeds.”

(m)The

Company and the Subsidiaries will maintain and keep accurate books and records reflecting their assets and maintain internal accounting

controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of

financial statements for external purposes in accordance with generally accepted accounting principles and including those policies and

procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions

and dispositions of the assets of the Company, (ii) provide reasonable assurance that transactions are recorded as necessary to permit

the preparation of the Company’s consolidated financial statements in accordance with generally accepted accounting principles,

(iii) receipts and expenditures of the Company are being made only in accordance with management’s and the Company’s

directors’ authorization and (iv) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition,

use or disposition of the Company’s assets that could have a material effect on its financial statements. The Company and the Subsidiaries

will maintain such controls and other procedures, including, without limitation, those required by Sections 302 and 906 of the Sarbanes-Oxley

Act, and the applicable regulations thereunder that are designed to ensure that information required to be disclosed by the Company in

the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified

in the Commission’s rules and forms, including, without limitation, controls and procedures designed to ensure that information

required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated

to the Company’s management, including its principal executive officer and principal financial officer, or persons performing similar

functions, as appropriate to allow timely decisions regarding required disclosure and to ensure that material information relating to

the Company or the Subsidiaries is made known to them by others within those entities, particularly during the period in which such periodic

reports are being prepared.

(n)Without

the prior written consent of the Sales Agent, the Company will not, directly or indirectly, offer to sell, sell, contract to sell, grant

any option to sell or otherwise dispose of any shares of Common Stock (other than the Placement Shares offered pursuant to this Agreement)

or securities convertible into or exchangeable or exercisable for shares of Common Stock, warrants or any rights to purchase or acquire,

shares of Common Stock during the period beginning on the second Trading Day immediately prior to the date on which any Placement Notice

is delivered to the Sales Agent hereunder and ending on the second Trading Day immediately following the final Settlement Date with respect

to Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has been terminated or suspended prior to the

sale of all Placement Shares covered by a Placement Notice, the date of such suspension or termination); and will not directly or indirectly

in any other “at the market offering” or equity line transaction offer to sell, sell, contract to sell, grant any option to

sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible

into or exchangeable or exercisable for shares of Common Stock, warrants or any rights to purchase or acquire, shares of Common Stock

prior to the later of the termination of this Agreement and the thirtieth day immediately following the final Settlement Date with respect

to Placement Shares sold pursuant to such Placement Notice; provided, however, that such restrictions will not be required

in connection with the Company’s: (i) issuance or sale of shares of Common Stock, options to purchase shares of Common Stock

or shares of Common Stock issuable upon the exercise of options, pursuant to any employee or director stock option or benefits plan, stock

ownership plan or dividend reinvestment plan (but not shares of Common Stock subject to a waiver to exceed plan limits in its dividend

reinvestment plan) of the Company whether now in effect or hereafter implemented, (ii) shares of Common Stock issuable upon conversion

of securities or the exercise of warrants, options or other rights in effect or outstanding, and disclosed in filings by the Company available

on EDGAR or otherwise in writing to the Sales Agent, (iii) issuance or sale of shares of Common Stock or securities convertible into or

exchangeable for shares of Common Stock as consideration for mergers, acquisitions, other business combinations or strategic alliances

occurring after the date of this Agreement which are not issued for capital raising purposes, (iv) modification of any outstanding equity

awards, warrants or any rights to purchase or acquire shares of Common Stock and (v) issuance of shares of Common Stock, or securities

convertible into, exercisable for or redeemable for shares of Common Stock, in a privately negotiated transaction to vendors, customers,

strategic partners or potential strategic partners as consideration for goods, services or strategic relationship arrangements, conducted

in a manner so as not to be integrated with the offering of the Placement Shares hereby and which are not issued for capital raising purposes.

(o)Prior

to the date of the first Placement Notice, the Company will use its reasonable best efforts to cause the Placement Shares to be listed

on the Exchange.

(p)The

Company will, at any time during the pendency of a Placement Notice, advise the Sales Agent promptly after it shall have received notice

or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate,

letter or other document required to be provided to the Sales Agent pursuant to this Agreement.

(q)The

Company will cooperate with any reasonable due diligence review conducted by the Sales Agent, its representatives and its counsel in connection

with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior

corporate officers, during regular business hours and at the Company’s principal offices, as the Sales Agent may reasonably request.

(r)The

Company agrees that on or prior to such dates as the Act shall require, the Company will (i) file a prospectus supplement with the

Commission under the applicable paragraph of Rule 424(b), which prospectus supplement will set forth, within the relevant period, the

number or amount of Placement Shares sold through the Sales Agent, the Net Proceeds to the Company and the compensation payable by the

Company to the Sales Agent with respect to such Placement Shares, and (ii) deliver such number of copies of each such prospectus

supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange

or market; provided, that, unless a prospectus supplement containing such information is required to be filed under the Act, the

requirement of this Section 7(r) may be satisfied by Company’s inclusion in the Company’s Form 10-K or Form 10-Q, as applicable,

of the number or amount of Placement Shares sold through the Sales Agent, the Net Proceeds to the Company and the compensation payable

by the Company to the Sales Agent with respect to such Placement Shares during the relevant period.

(s)Prior

to the date on which the Company first delivers a Placement Notice and each time the Company:

(i)files

the Prospectus relating to the Placement Shares or amends or supplements (other than a prospectus supplement relating solely to an offering

of securities other than the Placement Shares) the Registration Statement or the Prospectus relating to the Placement Shares by means

of a post-effective amendment, sticker or supplement but not by means of incorporation of documents by reference into the Registration

Statement or the Prospectus relating to the Placement Shares;

(ii)files

an annual report on Form 10-K under the Exchange Act (including any Form 10-K/A containing amended financial information or a material

amendment to the previously filed Form 10-K);

(iii)files

a quarterly report on Form 10-Q under the Exchange Act; or

(iv)files

a current report on Form 8-K containing amended financial information (other than information “furnished” pursuant to Items

2.02 or 7.01 of Form 8-K) under the Exchange Act (each date of filing of one or more of the documents referred to in clauses (i)

through (iv) shall be a “Representation Date”),

the Company shall furnish

the Sales Agent (but in the case of clause (iv) above only if the Sales Agent reasonably determines that the information contained in

such Form 8-K is material at a time when a Placement Notice is pending or in effect and the Sales Agent requests a certificate within

three Trading Days of the Company’s filing of such Form 8-K) with a certificate, in the form attached hereto, dated the Representation

Date, modified, as necessary, to relate to the Registration Statement and the Prospectus as amended or supplemented. The requirement to

provide a certificate under this Section 7(s) shall be waived for any Representation Date occurring at a time a Suspension is in effect,

which waiver shall continue until the earlier to occur of the date on which the Company delivers instructions for the sale of Placement

Shares hereunder (which for such calendar quarter shall be considered a Representation Date) and the next occurring Representation Date.

Notwithstanding the foregoing, if the Company subsequently decides to sell Placement Shares following a Representation Date when a Suspension

was in effect and did not provide the Sales Agent with a certificate under this Section 7(s), then before the Company delivers the instructions

for the sale of Placement Shares or the Sales Agent sells any Placement Shares pursuant to such instructions, the Company shall provide

the Sales Agent with a certificate in conformity with this Section 7(s) dated as of the date that the instructions for the sale of Placement

Shares are issued.

(t)Prior

to the date of the first Placement Notice and within five Trading Days of each Representation Date with respect to which the Company is

obligated to deliver a certificate pursuant to Section 7(s) for which no waiver is applicable, the Company shall cause to be furnished

to the Sales Agent a written opinion and negative assurance letter of ArentFox Schiff LLP (“Company Counsel”), or other counsel

satisfactory to the Sales Agent, in form and substance satisfactory to Sales Agent and its counsel, modified, as necessary, to relate

to the Registration Statement and the Prospectus as then amended or supplemented; provided, however, that in lieu of such

opinion or negative assurance letter for subsequent Representation Dates, Company counsel may furnish the Sales Agent with a letter (a

“Reliance Letter”) to the effect that the Sales Agent may rely on a prior opinion delivered under this Section 7(t) to the

same extent as if it were dated the date of such letter (except that statements in such prior opinion or negative assurance letter shall

be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of the date of the Reliance Letter).

(u)Prior

to the date of the first Placement Notice and within five Trading Days of each Representation Date with respect to which the Company is

obligated to deliver a certificate pursuant to Section 7(s) for which no waiver is applicable, the Company shall cause MaloneBailey, LLP

to furnish the Sales Agent letters (the “Comfort Letters”), dated the date the Comfort Letter is delivered, which shall meet

the requirements set forth in this Section 7(u); provided, that if requested by the Sales Agent, the Company shall cause a Comfort

Letter to be furnished to the Sales Agent within 10 Trading Days of the date of occurrence of any material transaction or event, including

the restatement of the Company’s financial statements. The Comfort Letter shall be in a form and substance satisfactory to the Sales

Agent, (i) confirming that they are an independent registered public accounting firm within the meaning of the Act and the PCAOB, (ii)

stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily

covered by accountants’ “comfort letters” to underwriters in connection with registered public offerings (the first

such letter, the “Initial Comfort Letter”) and (iii) updating the Initial Comfort Letter with any information that would have

been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement

and the Prospectus, as amended and supplemented to the date of such letter.

(v)If,

immediately prior to the third anniversary of the initial effective date of the Registration Statement (the “Renewal Date”),

any of the Placement Shares remain unsold and this Agreement has not been terminated, the Company will, prior to the Renewal Date, file

a new shelf registration statement or, if applicable, an automatic shelf registration statement relating to the Common Stock that may

be offered and sold pursuant to this Agreement (which shall include a prospectus reflecting the number or amount of Placement Shares that

may be offered and sold pursuant to this Agreement), in a form satisfactory to the Sales Agent and its counsel, and, if such registration

statement is not an automatic shelf registration statement, will use its best efforts to cause such registration statement to be declared

effective within 180 days after the Renewal Date. The Company will take all other reasonable actions necessary or appropriate to permit

the public offer and sale of the Placement Shares to continue as contemplated in the expired registration statement and this Agreement.

From and after the effective date thereof, references herein to the “Registration Statement” shall include such new shelf

registration statement or such new automatic shelf registration statement, as the case may be.

(w)If,

from and after the date of this Agreement, the Company is no longer eligible to use Form S-3 (including pursuant to General Instruction

I.B.6.) at the time it files with the Commission an annual report on Form 10-K or any post-effective amendment to the Registration Statement,

then it shall promptly notify the Sales Agent and, within two Business Days after the date of filing of such annual report on Form 10-K

or amendment to the Registration Statement, the Company shall file a new prospectus supplement with the Commission reflecting the number

of shares of Common Stock available to be offered and sold by the Company under this Agreement pursuant to General Instruction I.B.6.

of Form S-3; provided, however, that the Company may delay the filing of any such prospectus supplement for up to 30 days

if, in the reasonable judgment of the Company, it is in the best interest of the Company to do so, provided that no Placement Notice is

in effect or pending during such time. Until such time as the Company shall have corrected such misstatement or omission or effected such

compliance, the Company shall not notify the Sales Agent to resume the offering of Placement Shares.

(x)The

Company represents and agrees that, without the prior written consent of the Sales Agent, and the Sales Agent represents and agrees that,

without the prior written consent of the Company, it (including its agents and representatives, other than the Sales Agent in its capacity

as such) has not made and will not make, use, prepare, authorize, approve or refer to any written communication that constitutes an offer

to sell or solicitation of an offer to buy Placement Shares hereunder or otherwise make any offer relating to the Placement Shares that

would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined

in Rule 405), required to be filed with the Commission. Any such free writing prospectus the use of which has been consented to by the

Company and the Sales Agent, as the case may be, is herein called a “Permitted Free Writing Prospectus.” The Company represents

and agrees that it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus

and that it has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Rules and Regulations

applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission, where required, recordkeeping and legending.

For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in Schedule 4 hereto are Permitted

Free Writing Prospectuses.

8.Conditions

of the Obligations of the Sales Agent.

The obligations of the Sales

Agent hereunder with respect to a Placement will be subject to the continuing accuracy and completeness of the representations and warranties

made by the Company herein, to the due performance by the Company of its obligations hereunder, to the completion by the Sales Agent of

a due diligence review satisfactory to the Sales Agent, and to the continuing satisfaction (or waiver by the Sales Agent in its sole discretion)

of the following additional conditions:

(a)The

Registration Statement shall be effective and shall be available for the (i) resale of all Placement Shares issued to the Sales Agent

and not yet sold by the Sales Agent and (ii) sale of all Placement Shares contemplated to be issued by any Placement Notice. All filings

required by Rule 424 shall have been made, including timely filing of the Prospectus Supplement pursuant to Rule 424(b).

(b)

(i) No stop order suspending the effectiveness of the Registration Statement or preventing or suspending the use of the Prospectus Supplement,

the Prospectus or any Issuer Free Writing Prospectus shall have been issued and no proceedings for that purpose shall be pending or threatened

by the Commission; (ii) no order suspending the qualification or registration of the Placement Shares under the securities or Blue Sky

laws of any jurisdiction shall be in effect and no proceeding for such purpose shall be pending before or threatened or contemplated by

any applicable governmental authorities; (iii) the Company shall not have received any request for additional information from the Commission

or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to

which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus; (iv) there shall not

have occurred or be continuing any event that makes any material statement made in the Registration Statement or the Prospectus or any

material Incorporated Document untrue in any material respect or that requires the making of any changes in the Registration Statement,

the Prospectus or Incorporated Documents so that, in the case of the Registration Statement, it will not contain any untrue statement

of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading

and, in the case of the Prospectus, so that it will not contain any untrue statement of a material fact or omit to state any material

fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were

made, not misleading.

(c)The

Sales Agent shall not have advised the Company that the Registration Statement or the Prospectus, or any amendment or supplement thereto,

contains an untrue statement of fact that in the Sales Agent’s opinion is material, or omits to state a fact that in the Sales Agent’s

opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading.

(d)Except

as contemplated in the Prospectus, or disclosed in the Company’s reports filed with the Commission, (i) there shall not have

been (A) a Material Adverse Change or any material adverse change, on a consolidated basis, in the authorized capital stock of the Company,

(B) any Material Adverse Effect or the occurrence of any development that the Company reasonably expects could result in a Material Adverse

Effect or (C) any downgrading in or withdrawal of the rating assigned to any of the Company’s securities (other than asset-backed

securities), if any, by any rating organization or a public announcement by any rating organization that it has under surveillance or

review its rating of any of the Company’s securities (other than asset-backed securities), if any, and (ii) neither the Company

nor any of its Subsidiaries shall have sustained any material loss or interference with its business or properties from fire, explosion,

flood or other casualty, whether or not covered by insurance, or from any labor dispute or any court or legislative or other governmental

action, order or decree, if in the judgment of the Sales Agent (without relieving the Company of any obligation or liability it may otherwise

have), any such development makes it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and

in the manner contemplated in the Prospectus.

(e)Since

the respective dates as of which information is given in the Registration Statement and the Prospectus, there shall have been no litigation

or other proceeding instituted against the Company, any of its Subsidiaries or any of its or their officers or directors in their capacities

as such, before or by any federal, state or local court, commission, regulatory body, administrative agency or other governmental body,

domestic or foreign, in which litigation or proceeding an unfavorable ruling, decision or finding could, in the judgment of the Sales

Agent, have a Material Adverse Effect or if, in the judgment of the Sales Agent, any such development makes it impracticable or inadvisable

to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.

(f)Each

of the representations and warranties of the Company contained herein shall be true and correct in all respects (in the case of any representation

and warranty containing a materiality or Material Adverse Effect qualification) or in all material respects (in the case of any other

representation and warranty), and all covenants and agreements contained herein to be performed on the part of the Company and all conditions

contained herein to be fulfilled or complied with by the Company shall have been duly performed, fulfilled or complied with.

(g)The

Sales Agent shall have received the opinion and negative assurance letter from Company Counsel required to be delivered pursuant to Section

7(t) on or before the date on which delivery of such opinion and negative assurance letter is required pursuant to Section 7(t).

(h)The

Sales Agent shall have received an opinion and negative assurance letter from White & Case LLP, counsel to the Sales Agent, on or

before the date on which delivery of the opinion of Company Counsel is required pursuant to Section 7(t), which opinion and negative assurance

letter shall be reasonably satisfactory in all respects to the Sales Agent, and the Company shall have furnished to such counsel such

documents as they may request to enable counsel to the Sales Agent to pass upon such matters.

(i)The

Sales Agent shall have received the Comfort Letter required to be delivered pursuant to Section 7(u) on or before the date on which such

delivery of such Comfort Letter is required pursuant to Section 7(u).

(j)The

Sales Agent shall have received the certificate required to be delivered pursuant to Section 7(s) on or before the date on which delivery

of such certificate is required pursuant to Section 7(s).

(k)Prior

to the date of the first Placement Notice and at subsequent Representation Dates as may be requested by the Sales Agent, the Company shall

deliver to the Sales Agent a certificate of the Secretary of the Company and attested to by an executive officer of the Company, dated

as of such date and in form and substance satisfactory to the Sales Agent and its counsel, certifying as to (i) the Certificate of Incorporation

of the Company, (ii) the By-laws of the Company, (iii) the resolutions of the board of directors of the Company or a duly authorized committee

thereof authorizing the execution, delivery and performance of this Agreement and the issuance of the Placement Shares and (iv) the incumbency

of the officers duly authorized to execute this Agreement and the other documents contemplated by this Agreement.

(l)The

Placement Shares shall be qualified for sale in such jurisdictions as the Sales Agent may reasonably request and each such qualification

shall be in effect and not subject to any stop order or other proceeding.

(m)Either

(i) the Placement Shares shall have been approved for listing on the Exchange, subject only to notice of issuance, or (ii) the Company

shall have filed an application for listing of the Placement Shares on the Exchange at, or prior to, the issuance of the first Placement

Notice and the Exchange shall have reviewed such application and not provided any objections thereto. Trading in the Common Stock shall

not have been suspended on the Exchange and the Common Stock shall not have been delisted from the Exchange.

(n)All

filings with the Commission required by Rule 424(b) or Rule 433 under the Act to have been filed prior to the issuance of any Placement

Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424(b) (without reliance on

Rule 424(b)(8)) or Rule 433, as applicable.

(o)If

applicable, FINRA shall have raised no objection to the terms of the offering contemplated hereby and the amount of compensation allowable

or payable to the Sales Agent as described in the Prospectus.

(p)On

each date on which the Company is required to deliver a certificate pursuant to Section 7(s), the Company shall have furnished to the

Sales Agent such further information, opinions, certificates, letters and other documents, in addition to those specifically mentioned

herein, as the Sales Agent may have reasonably requested. All such information, opinions, certificates, letters and other documents shall

have been in compliance with the provisions hereof.

(q)There

shall not have occurred any event that would permit the Sales Agent to terminate this Agreement pursuant to Section 11(a).

(r)Reserved.

9.Indemnification

and Contribution.

(a)The

Company will indemnify and hold harmless the Sales Agent, its partners, members, directors, officers, employees, agents and affiliates

and each person, if any, who controls the Sales Agent within the meaning of Section 15 of the Act or Section 20 of the Exchange

Act, from and against any and all losses, claims, liabilities, expenses and damages (including any and all investigative, legal and other

expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted),

to which they, or any of them, may become subject under the Act, the Exchange Act or other federal or state statutory law or regulation,

at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based on any untrue statement

or alleged untrue statement of a material fact contained in the Registration Statement, Prospectus Supplement, the Prospectus or any amendment

or supplement thereto or any Issuer Free Writing Prospectus or any “issuer information” filed or required to be filed pursuant

to Rule 433(d) of the Rules and Regulations, or the omission or alleged omission to state in such document a material fact required to

be stated in it or necessary to make the statements in it not misleading in the light of the circumstances in which they were made, or

arise out of or are based in whole or in part on any inaccuracy in the representations and warranties of the Company contained herein

or any failure of the Company to perform its obligations hereunder or under law in connection with the transactions contemplated hereby;

provided, however, that the Company will not be liable to the extent that such loss, claim, liability, expense or damage

arises from the sale of the Placement Shares to any person by the Sales Agent and is based on the Sales Agent Information. This indemnity

agreement will be in addition to any liability that the Company might otherwise have.

(b)The

Sales Agent will indemnify and hold harmless the Company, each director of the Company, each officer of the Company who signs the Registration

Statement, and each person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20 of the

Exchange Act, to the same extent as the foregoing indemnity from the Company to Sales Agent, as set forth in Section 9(a), but only insofar

as losses, claims, liabilities, expenses or damages arise out of or are based on any untrue statement or omission or alleged untrue statement

or omission made in reliance on and in conformity with the Sales Agent Information. This indemnity will be in addition to any liability

that the Sales Agent might otherwise have.

(c)Any

party that proposes to assert the right to be indemnified under this Section 9 shall, promptly after receipt of notice of commencement

of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this Section 9,

notify each such indemnifying party in writing of the commencement of such action, enclosing with such notice a copy of all papers served,

but the omission so to notify such indemnifying party will not relieve it from any liability that it may have to any indemnified party

under the foregoing provisions of this Section 9 unless, and only to the extent that, such omission results in the loss of substantive

rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying

party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written

notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly

with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the

indemnified party. After notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying

party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable

costs of investigation incurred by the indemnified party in connection with the defense. The indemnified party will have the right to

employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified

party unless (i) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (ii) the

indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified

parties that are different from or in addition to those available to the indemnifying party, (iii) a conflict or potential conflict

exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the

indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party), or (iv) the

indemnifying party has not in fact employed counsel reasonably satisfactory to the indemnified party to assume the defense of such action

within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable fees, disbursements

and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party

or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable

fees, disbursements and other charges of more than one separate firm (plus local counsel) admitted to practice in such jurisdiction at

any one time for all such indemnified party or parties. All such reasonable fees, disbursements and other charges will be reimbursed by

the indemnifying party promptly as they are incurred. No indemnifying party shall, without the prior written consent of the indemnified

party, effect any settlement of any pending or threatened action in respect of which any indemnified party is or could have been a party

and indemnity could have been sought hereunder by such indemnified party unless such settlement (A) includes an unconditional release

of such indemnified party, in form and substance reasonably satisfactory to the indemnified party, from all liability on any claims that

are the subject matter of such action and (B) does not include a statement as to, or an admission of, fault, culpability or a failure

to act by or on behalf of an indemnified party. An indemnifying party will not be liable for any settlement of any action or claim effected

without its written consent (which consent will not be unreasonably withheld or delayed).

(d)If

an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for reasonable fees and expenses of

counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by this Section 9 effected

without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of

the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior

to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance

with such request prior to the date of such settlement.

(e)If

the indemnification provided for in this Section 9 is applicable in accordance with its terms but for any reason is held to be unavailable

to or insufficient to hold harmless an indemnified party under this Section 9 in respect of any losses, claims, liabilities, expenses

and damages referred to therein, then each applicable indemnifying party, in lieu of indemnifying such indemnified party, shall contribute

to the amount paid or payable (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount

paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company

from persons other than the Sales Agent, such as persons who control the Company within the meaning of the Act, officers of the Company

who signed the Registration Statement and directors of the Company, who also may be liable for contribution) by such indemnified party

as a result of such losses, claims, liabilities, expenses and damages in such proportion as shall be appropriate to reflect the relative

benefits received by the Company, on the one hand, and the Sales Agent, on the other hand. The relative benefits received by the Company,

on the one hand, and the Sales Agent, on the other hand, shall be deemed to be in the same proportion as the total Net Proceeds from the

sale of the Placement Shares (before deducting expenses) received by the Company bear to the total compensation received by the Sales

Agent from the sale of the Placement Shares on behalf of the Company. If, but only if, the allocation provided by the foregoing sentence

is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only

the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Sales

Agent, on the other hand, with respect to the statements or omissions that resulted in such loss, claim, liability, expense or damage,

or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault

shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission

to state a material fact relates to information supplied by the Company or the Sales Agent, the intent of the parties and their relative

knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Sales Agent agree

that it would not be just and equitable if contributions pursuant to this Section 9(e) were to be determined by pro rata allocation or

by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or

payable by an indemnified party as a result of the loss claim, liability, expense or damage, or action in respect thereof, referred to

above in this Section 9(e) shall be deemed to include, for purposes of this Section 9(e), any legal or other expenses reasonably incurred

by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this

Section 9(e), the Sales Agent shall not be required to contribute any amount in excess of the commissions received by it and no person

found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) will be entitled to contribution from any

person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 9(e), any person who controls a party to

this Agreement within the meaning of the Act will have the same rights to contribution as that party, and each officer of the Company

who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions

hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against any such party in respect

of which a claim for contribution may be made under this Section 9(e), will notify any such party or parties from whom contribution may

be sought, but the omission so to notify will not relieve the party or parties from whom contribution may be sought from any other obligation

it or they may have under this Section 9(e). No party will be liable for contribution with respect to any action or claim settled without

its written consent if such consent is required pursuant to Section 9 hereof.

(f)The

indemnity and contribution agreements contained in this Section 9 and the representations and warranties of the Company contained

in this Agreement shall remain operative and in full force and effect regardless of (i) any investigation made by or on behalf of

the Sales Agent, (ii) acceptance of any of the Placement Shares and payment therefor or (iii) any termination of this Agreement.

10.Reimbursement

of Certain Expenses.

In addition to its other obligations

under Section 9(a) of this Agreement, the Company hereby agrees to reimburse the Sales Agent on a quarterly basis for all reasonable

legal and other expenses incurred in connection with investigating or defending any claim, action, investigation, inquiry or other proceeding

arising out of or based upon, in whole or in part, any statement or omission or alleged statement or omission or any inaccuracy in the

representations and warranties of the Company contained herein or failure of the Company to perform its obligations hereunder or under

law, all as described in Section 9(a), notwithstanding the absence of a judicial determination as to the propriety and enforceability

of the obligations under this Section 10 and the possibility that such payment might later be held to be improper; provided,

however, that, to the extent any such payment is ultimately held to be improper, the persons receiving such payments shall promptly

refund them.

11.Termination.

(a)The

obligations of the Sales Agent under this Agreement may be terminated and the Sales Agent may terminate this Agreement at any time, by

notice to the Company from the Sales Agent, without liability on the part of the Sales Agent to the Company if, in the sole judgment of

the Sales Agent, (i) there has been, since the time of execution of this Agreement or since the date as of which information is given

in the Prospectus, any Material Adverse Effect, any Material Adverse Change or any development that could reasonably be expected to result

in a Material Adverse Effect or a Material Adverse Change, whether or not arising in the ordinary course of business, which individually

or in the aggregate, in the sole judgment of the Sales Agent is material and adverse and makes it impractical or inadvisable to sell the

Placement Shares or to enforce contracts for the sale of the Placement Shares, (ii) trading in any of the equity securities of the

Company shall have been suspended or limited by the Commission or by the Exchange or trading of any securities of the Company on any exchange

or in the over-the-counter market shall have occurred and be continuing, (iii) trading in securities generally on the Exchange shall

have been suspended or limited or minimum or maximum prices shall have been generally established on the Exchange, or material governmental

restrictions shall have been imposed upon trading in securities generally by the Exchange, by order of the Commission or any court or

other governmental authority or by the Exchange, (iv) a banking moratorium shall have been declared by either federal or New York

State authorities or any material disruption of the securities settlement or clearance services in the United States shall have occurred,

or (v) any material adverse change in the financial or securities markets in the United States or elsewhere or in political, financial

or economic conditions in the United States or elsewhere, any outbreak or material escalation of hostilities, a declaration of a national

emergency or war, or other calamity or crisis, either within or outside the United States, shall have occurred, the effect of which is

such as to make it, in the sole judgment of the Sales Agent, impracticable or inadvisable to sell the Placement Shares or to enforce contracts

for the sale of the Placement Shares. If this Agreement is terminated pursuant to this Section 11(a), neither party shall have any

liability to the other party, except that Sections 7(i), 9, 10 and 13 hereof shall remain in full force and effect notwithstanding such

termination; If the Sales Agent elects to terminate this Agreement as provided in this Section 11(a), the Sales Agent shall provide the

required notice as specified in Section 13.

(b)The

Company shall have the right, by giving five days’ prior notice as hereinafter specified to terminate this Agreement in its sole

discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party

except that the provisions of Sections 7(i), 9, 10 and 13 hereof shall remain in full force and effect notwithstanding such termination.

(c)The

Sales Agent shall have the right, by giving five days’ prior notice as hereinafter specified to terminate this Agreement in its

sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other

party except that the provisions of Sections 7(i), 9, 10 and 13 hereof shall remain in full force and effect notwithstanding such termination.

(d)This

Agreement shall remain in full force and effect unless terminated pursuant to Sections 11(a), (b), or (c) above or otherwise by mutual

agreement of the parties; provided, however, that any such termination by mutual agreement shall in all cases be deemed

to provide that Sections 7(i), 9, 10 and 13 hereof shall remain in full force and effect.

(e)Any

termination of this Agreement shall be effective on the date specified in such notice of termination; provided, however,

that such termination shall not be effective until the close of business on the date of receipt of such notice by the Sales Agent or the

Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement

Shares shall settle in accordance with the provisions of this Agreement.

12.No

Fiduciary Relationship.

Notwithstanding any preexisting

relationship, advisory or otherwise, between the parties or any oral representations or assurances previously or subsequently made by

the Sales Agent, the Company acknowledges and agrees that (a) the offering and sale of the Placement Shares pursuant to this Agreement

is an arm’s-length commercial transaction between the Company and the Sales Agent,(b) the Sales Agent is acting solely as agent

in connection with the public offering of the Placement Shares and in connection with each transaction contemplated by this Agreement

and the process leading to such transactions, and the Sales Agent has not assumed an advisory or fiduciary responsibility in favor of

the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether the Sales Agent has

advised or is currently advising the Company on other matters) or any other obligation to the Company except the obligations expressly

set forth in this Agreement, (c) the Sales Agent and its affiliates may be engaged in a broad range of transactions that involve interests

that differ from those of the Company and the Sales Agent has no obligation to disclose or account to the Company for any of such differing

interests, and (d) the Company has consulted its own legal, tax, accounting and financial advisors to the extent it deemed appropriate,

is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated

by this Agreement and has not relied upon the Sales Agent or legal counsel for the Sales Agent for any legal, tax, accounting and financial

advice in connection with the offering and sale of the Placement Shares. The Company hereby waives any claim, and agrees that it

will not claim, that the Sales Agent or its affiliates have rendered advisory services of any nature or respect, or owe a fiduciary or

similar duty to the Company, in connection with the sale of Placement Shares under this Agreement or the process leading thereto. The

Company agrees that the Sales Agent and its affiliates shall not have any liability (whether direct or indirect, in contract, tort or

otherwise) to it in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on its behalf or in right

of it or the Company, employees or creditors of Company.

13.Miscellaneous.

(a)Notice given

pursuant to any of the provisions of this Agreement shall be in writing and, unless otherwise specified, shall be mailed or delivered

(a) if to the Company, at the office of the Company, NeoVolta, Inc., 12195 Dearborn Place, Poway, CA 92064, Attention: Steve Bond,

CFO, email: [omitted], with a copy (which shall not constitute notice) to ArentFox Schiff LLP, Attention: Cavas Pavri, facsimile: (202)

857-6395, email [omitted], or (b) if to the Sales Agent at the offices of Needham & Company, LLC, 250 Park Avenue,

New York, NY 10177, Attention: Corporate Finance Department, facsimile: Matthew Castrovince email: [omitted], with a copy (which shall

not constitute notice) to White & Case LLP, 1221 Avenue of the Americas, New York, NY 10020, Attention: Drew Valentine, email [omitted].

Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new

address for such purpose. Each such notice or other communication shall be deemed given (i) when delivered personally or by verifiable

facsimile transmission (with an original to follow) on or before 4:30 p.m., New York City time, on a Business Day or, if such day

is not a Business Day, on the next succeeding Business Day, (ii) on the next Business Day after timely delivery to a nationally-recognized

overnight courier, (iii) on the Business Day actually received if deposited in the U.S. mail (certified or registered mail, return

receipt requested, postage prepaid) and (iv) by Electronic Notice as set forth in the following paragraph. For purposes of this Agreement,

“Business Day” shall mean any day on which the Exchange and commercial banks in New York City are open for business.

An electronic communication

(“Electronic Notice”) shall be deemed written notice for purposes of this Section 13(a) if sent to the electronic mail address

specified by the receiving party in this Section 13(a). Electronic Notice shall be deemed received at the time the party sending Electronic

Notice receives actual acknowledgment of receipt from the person to whom notice is sent, other than automatic reply. Any party receiving

Electronic Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form (“Nonelectronic Notice”),

which shall be sent to the requesting party within 10 days of receipt of the written request for Nonelectronic Notice.

(b)This

Agreement has been and is made solely for the benefit of the Sales Agent, the Company, and the persons referred to in Section 9,

and their respective successors and permitted assigns, and no other person shall acquire or have any right under or by virtue of this

Agreement. The term “successors and assigns” as used in this Agreement shall not include a purchaser, as such purchaser, of

Placement Shares. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other

party; provided, however, that the Sales Agent may assign its rights and obligations hereunder to an affiliate thereof without

obtaining the Company’s consent.

(c)The

parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any stock

split, stock dividend or similar event effected with respect to the Common Stock.

(d)This

Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement

and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard

to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed

by the Company and the Sales Agent.

(e)This

Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to

be performed entirely within such State and without regard to principles of conflicts of laws. Unless stated otherwise, specified times

of day refer to New York City time.

(f)No

implied waiver by a party shall arise in the absence of a waiver in writing signed by such party. No failure or delay in exercising any

right, power, or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any

other or further exercise thereof or the exercise of any right, power, or privilege hereunder.

(g)This

Agreement may be signed in two or more counterparts with the same effect as if the signatures thereto and hereto were upon the same instrument.

Delivery of an executed Agreement by one party to the other may be made by facsimile or electronic transmission (including any electronic

signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act

or other applicable law) and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective

for all purposes.

(h)In

the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal

or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest

possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if

such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision

and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement.

(i)EACH

OF THE COMPANY AND THE AGENT HEREBY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY CLAIM BASED UPON, RELATING TO OR

ARISING OUT OF THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

(j)Each

party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in New York City, Borough of Manhattan,

for the adjudication of any dispute hereunder or in connection with any of the transactions contemplated hereby, and hereby irrevocably

waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of

any such court, that such suit, action or proceeding is brought in an inconvenient forum, or that the venue of such suit, action or proceeding

is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action

or proceeding by mailing a copy (certified or registered mail, return receipt requested) to such party at the address in effect for notices

under Section 13(a) of this Agreement and agrees that such service shall constitute good and sufficient notice of process and notice thereof.

Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.

(k)In

accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Agent is

required to obtain, verify and record information that identifies its clients, including the Company, which information may include the

name and address of its clients, as well as other information that will allow the Agent to properly identify its clients.

(l)For

purposes of this Agreement:

(i)The

section, exhibit and schedule headings herein are for convenience only and shall not affect the construction hereof.

(ii)Words

defined in the singular shall have a comparable meaning when used in the plural, and vice versa.

(iii)The

words “hereof,” “hereto,” “herein” and “hereunder” and words of similar import, when used

in this Agreement, shall refer to this Agreement as a whole and not to any particular provision of this Agreement.

(iv)Wherever

the word “include,” “includes” or “including” is used in this Agreement, it shall be deemed to be

followed by the words “without limitation.”

(v)References

herein to any gender shall include each other gender.

(vi)References

herein to any law, statute, ordinance, code, regulation, rule or other requirement of any governmental authority shall be deemed to refer

to such law, statute, ordinance, code, regulation, rule or other requirement of any governmental authority as amended, reenacted, supplemented

or superseded in whole or in part and in effect from time to time and also to all rules and regulations promulgated thereunder.

(vii)All

references in this Agreement to financial statements and schedules and other information that is “contained,” “included”

or “stated” in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean

and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement

or the Prospectus, as the case may be.

(viii)All

references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall

be deemed to include the copy filed with the Commission pursuant to EDGAR; all references in this Agreement to any Issuer Free Writing

Prospectus (other than any Issuer Free Writing Prospectuses that, pursuant to Rule 433, are not required to be filed with the Commission)

shall be deemed to include the copy thereof filed with the Commission pursuant to EDGAR; and all references in this Agreement to “supplements”

to the Prospectus shall include, without limitation, any supplements, “wrappers” or similar materials prepared in connection

with any offering, sale or private placement of any Placement Shares by the Sales Agent outside of the United States.

14.Recognition

of the U.S. Special Resolution Regimes.

(a)In

the event that any Agent that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer

from such Sales Agent of this Agreement or any Terms Agreement, and any interest and obligation in or under this Agreement or any Terms

Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement

or any Terms Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United

States.

(b)In

the event that any Sales Agent that is a Covered Entity or a BHC Act Affiliate of such Sales Agent becomes subject to a proceeding under

a U.S. Special Resolution Regime, Default Rights under this Agreement or any Terms Agreement that may be exercised against such Sales

Agent are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution

Regime if this Agreement or any Terms Agreement were governed by the laws of the United States or a state of the United States.

As used in this

Section 14:

“BHC Act Affiliate”

has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k).

“Covered Entity”

means any of the following:

(i)a

“covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);

(ii)a

“covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or

(iii)a

“covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).

“Default Right”

has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as

applicable.

“U.S. Special

Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title

II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.

[Signature pages follow]

Please confirm that the foregoing

correctly sets forth the agreement among the Company and the Sales Agent.

Very truly yours,

NeoVolta, Inc.

By:/s/ Steve Bond

Name: Steve Bond

Title: CFO & Director

Confirmed as of the date first

above mentioned:

Needham

& Company, LLC

By: /s/ Matthew Castrovince

Name: Matthew Castrovince

Title: Managing Director

SCHEDULE 1

__________________________

Form of Placement Notice

__________________________

From: NeoVolta, Inc.

To: Needham & Company, LLC

Attention: Matthew Castrovince

Subject: Placement Notice

Date: [____], 20[____]

Ladies and Gentlemen:

Pursuant to the terms and

subject to the conditions contained in the Sales Agreement between NeoVolta, Inc., a Nevada corporation (the “Company”), and

Needham & Company, LLC (the “Sales Agent”), dated [___], 2026, the Company hereby requests that the Sales Agent sell up

to [___] shares of the Company’s common stock, par value $0.001 per share (the “Shares”), at a minimum price of $[___]

per share, during the time period beginning [month, day, time] and ending [month, day, time][until all Shares that are the subject of

this Placement Notice are sold].

SCHEDULE 2

__________________________

Compensation

__________________________

The Company shall pay to the

Sales Agent in cash, upon each sale of Placement Shares pursuant to the Sales Agreement of which this Schedule 2 forms a part, an amount

equal to 3% of the aggregate gross proceeds from each sale of Placement Shares.

Capitalized terms used but not defined herein shall

have the meanings ascribed to them in the Sales Agreement.

SCHEDULE 3

__________________________

Notice Parties

_________________________

[Omitted]

SCHEDULE 4

__________________________

Permitted Free Writing Prospectus

__________________________

None.

__________________________

Form of Representation Date Certificate

__________________________

[Omitted]

EX-5.1 — OPINION OF ARENTFOX SCHIFF LLP

EX-5.1

Filename: neovolta_ex0501.htm · Sequence: 3

Exhibit 5.1

ArentFox Schiff LLP

1717 K Street NW

Washington, DC 20006

202.857.6000 MAIN

202.857.6395 FAX

afslaw.com

March 27, 2026

NeoVolta, Inc.

12195 Dearborn Place

Poway, CA 92064

Ladies and Gentlemen:

We have acted as counsel to

NeoVolta, Inc., a Nevada corporation (the "Company"), in connection with the Registration Statement on Form S-3, Registration

No. 333-280400 (as amended, the "Registration Statement"), filed by the Company with the Securities and Exchange Commission

(the "Commission") under the Securities Act of 1933, as amended (the "Securities Act"). The Registration Statement,

which was declared effective on June 28, 2024, relates to the issuance and sale from time to time, pursuant to Rule 415 of the rules and

regulations promulgated under the Securities Act, of, among other securities, shares of the Company's common stock, par value $0.001 per

share (the "Common Stock").

We have also acted as counsel

to the Company in connection with the issuance, offer, and sale from time to time of up to an aggregate of $30,000,000 of Common Stock

(the "Shares"), pursuant to the Sales Agreement, dated March 27, 2026, by and between the Company and Needham & Company,

LLC, as sales agent (the "Sales Agreement").

This opinion letter is being

delivered in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.

In connection with our opinion,

we have examined the Registration Statement, including the exhibits thereto, the Sales Agreement, and such other documents, corporate

records and instruments, and have examined such laws and regulations, as we have deemed necessary for the purposes of this opinion. In

making our examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals,

the conformity with the originals of all documents submitted to us as copies and the legal capacity of all natural persons. As to matters

of fact material to our opinions in this letter, we have relied on certificates and statements from officers and other employees of the

Company, public officials and other appropriate persons.

For purposes of the opinion

set forth below, we have assumed that the Shares are issued for a price per share equal to or greater than the minimum price authorized

by the Company’s board of directors prior to the date hereof, and that in the future the Company does not issue shares of Common

Stock, or reduce the total number of shares of Common Stock that the Company is authorized to issue under its certificate of incorporation,

such that the number of authorized but unissued shares of Common Stock under the Company’s certificate of incorporation is less

than the number of unissued Shares that may be issued for such minimum price.

Smart

Your World®

Page 2

Based on the foregoing and

subject to the qualifications set forth below, we are of the opinion that the Shares have been duly authorized and reserved for issuance

and, when issued by the Company and delivered by the Company against payment therefor as contemplated by the Sales Agreement and a Placement

Notice (as defined in the Sales Agreement), will be legally issued, fully paid and non-assessable.

The foregoing opinions are

limited to Chapter 78 of the Nevada Revised Statutes, and we express no opinion as to the laws of any other jurisdiction.

The opinions expressed in

this opinion letter are as of the date of this opinion letter only and as to laws covered hereby only as they are in effect on that date,

and we assume no obligation to update or supplement such opinion to reflect any facts or circumstances that may come to our attention

after that date or any changes in law that may occur or become effective after that date. The opinions herein are limited to the matters

expressly set forth in this opinion letter, and no opinion or representation is given or may be inferred beyond the opinions expressly

set forth in this opinion letter.

We hereby consent to the filing

of this opinion as Exhibit 5.1 to the Current Report on Form 8-K of the Company filed March 27, 2026, and to the reference to us under

the caption “Legal Matters” in the prospectus supplement with respect to the Shares and under the caption “Legal Matters”

in the prospectus contained in the Registration Statement. In giving this consent, we do not thereby admit that we are within the category

of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated

thereunder.

Very truly yours,

/s/ ArentFox Schiff, LLP

ArentFox Schiff, LLP

EX-10.1 — FIRST AMENDMENT TO EMPLOYMENT AGREEMENT

EX-10.1

Filename: neovolta_ex1001.htm · Sequence: 4

Exhibit 10.1

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT

This First Amendment to Employment

Agreement (this “Amendment”) is entered into as of March 25, 2026, by and between NeoVolta Inc., a Nevada corporation

(the “Company”), and Steve Bond (“Executive”).

RECITALS

WHEREAS, the Company and Executive

are parties to that certain Employment Agreement, dated as of February 4, 2025 (the “Employment Agreement”); and

WHEREAS, the Company and Executive

desire to amend the Employment Agreement to modify Executive’s title and role as set forth herein.

NOW, THEREFORE, in consideration

of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of

which are hereby acknowledged, the parties agree as follows:

AGREEMENT

1. Appointment

as Executive Vice President. Effective as of the date of this Amendment, Executive shall serve as Executive Vice President of

the Company, subject to the terms and conditions of the Employment Agreement, as amended hereby. All references to Executive’s title

or position in the Employment Agreement shall be deemed amended to refer to the title of Executive Vice President.

2. Transition

of Chief Financial Officer Role. Executive’s service as Chief Financial Officer of the Company shall terminate effective

as of May 18, 2026. From and after May 18, 2026, Executive shall no longer serve in the capacity of Chief Financial Officer and shall

have no further duties or responsibilities associated with such role. For the avoidance of doubt, Executive shall continue to serve as

Executive Vice President of the Company following the termination of his Chief Financial Officer role, and the Employment Agreement, as

amended hereby, shall remain in full force and effect with respect to Executive’s continued service as Executive Vice President.

3. No

Other Amendments. Except as expressly modified by this Amendment, the Employment Agreement shall remain in full force and effect

in accordance with its terms. In the event of any conflict between the terms of this Amendment and the terms of the Employment Agreement,

the terms of this Amendment shall control.

4. Waiver

of Good Reason. Executive hereby acknowledges and agrees that the modifications to Executive's title, position, duties, and responsibilities

contemplated by this Amendment, including without limitation the appointment of Executive as Executive Vice President and the termination

of Executive's service as Chief Financial Officer, do not and shall not constitute “Good Reason” (as defined in the Employment

Agreement) for Executive to terminate his employment with the Company. Executive hereby irrevocably waives any right to assert that any

of the foregoing changes constitute Good Reason or otherwise give rise to any right to resign for Good Reason under the Employment Agreement.

5.Defined

Terms. Capitalized terms used but not defined in this Amendment shall have the meanings ascribed to them in the Employment Agreement.

6. Counterparts.

This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall

constitute one and the same instrument.

7. Governing

Law. This Amendment shall be governed by and construed in accordance with the laws of the State of Nevada, without regard to its

conflicts of law principles.

IN WITNESS WHEREOF, the parties

have executed this Amendment as of the date first written above.

NEOVOLTA INC.

By: /s/ Ardes Johnson_____________________

Name: Ardes Johnson

Title: Chief Executive Officer

EXECUTIVE

/s/ Steve Bond____________________________

Steve Bond

GRAPHIC

Filename: image_001.jpg · Sequence: 5

Binary file (8573 bytes)

Download image_001.jpg

GRAPHIC

Filename: image_002.jpg · Sequence: 6

Binary file (8573 bytes)

Download image_002.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 12

v3.26.1

Cover

Mar. 26, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Mar. 26, 2026

Entity File Number

001-41447

Entity Registrant Name

NeoVolta,

Inc.

Entity Central Index Key

0001748137

Entity Tax Identification Number

82-5299263

Entity Incorporation, State or Country Code

Entity Address, Address Line One

12195

Dearborn Place

Entity Address, City or Town

Poway

Entity Address, State or Province

Entity Address, Postal Zip Code

92064

City Area Code

(800)

Local Phone Number

364-5464

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Common Stock [Member]

Title of 12(b) Security

Common Stock, par value $0.001 per share

Trading Symbol

NEOV

Security Exchange Name

NASDAQ

Warrant [Member]

Title of 12(b) Security

Warrants

Trading Symbol

NEOVW

Security Exchange Name

NASDAQ

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: